Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 6:00-7:30 h. 6:00 7:30 Auditorium A Track: Training in Dual Diagnosis 6:00 7:30 Auditorium B Track: Psychotherapeutic Treatment in Dual 6:00 7:30 Room Track: Behavioral addictions / Gambling Debate Forum - DF0 DUAL DISORDERS IN SCIENTIFIC JOURNALS Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine University of Miami. FL, USA. JOURNAL OF DUAL DIAGNOSIS Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. REVISTA DE PATOLOGÍA DUAL Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid, España. EUROPEAN ADDICTION RESEARCH Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. ACTAS ESPAÑOLAS DE PSIQUIATRÍA Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. ADVANCES ON DUAL DIAGNOSIS Gail Gilchrist, King's College London, United Kingdom. Symposium SY0 TREATMENT OF DUAL DISORDERS IN ADOLESCENTS AND YOUNG ADULTS WITH PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH Daniela Polese, University "Federico II" of Naples, Italy. THE POSSIBILITY OF TREATING DUAL DISORDERS IN YOUNG POPULATION THROUGH PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH Daniela Polese, University "Federico II" of Naples, Italy. SEVERE MENTAL ILLNESSES, DUAL DIAGNOSIS AND VIOLENCE: A PSYCHOTHERAPEUTIC PROSPECTIVE FOR FORENSIC PSYCHIATRY Niccolò Trevisan, Italian Society of Criminology, Italy. PSYCHOTHERAPY PRACTICE OF DUAL PSYCHOPATHOLOGY IN YOUNG IN A COOPERATIVE SERVICE OF MEDICAL PSYCHOTHERAPY Piera Galeandro, Cooperativa Sociale di Psicoterapia Medica, Italy. PRELIMINARY DATA FROM AN EARLY DETECTION STUDY CONDUCTED IN CHILD AND ADOLESCENT COMMUNITY CENTERS Paolo Fiori, "Sapienza" Università di Roma, Italy. Symposium SY0 IS EMOTIONAL DEPENDENCE A BEHAVIORAL ADDICTION WITHIN DUAL DISORDERS? Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España. FRAMEWORK OF EMOTIONAL BEHAVIORAL ADDICTION UNIT AND WITHIN THE RANGE OF DUAL DIAGNOSIS www.cipd05.com Pág.
Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Mª Nieves Gómez, Ayuntamiento San Sebastian de los Reyes, Madrid, España. EMOTIONAL DEPENDENCY IN DAILY PRACTICES OF FAMILY PHYSICIANS: INTERVENTION AND BIOLOGISTIC BASIS Juan A. López, Hospital de Octubre, CS Las Calesas, Madrid, España. TRANSVERSAL EMOTIONAL DEPENDENCY TREATMENT IN A THERAPEUTIC COMMUNITY FOR DUAL PATIENTS 6:00 7:30 Room -3 Track: Multidisciplinary Intervention in Dual 6:00 7:30 Room 4 Track: Depression 6:00 7:30 Room 5 Track: Bipolar 6:00 7:30 Room 6 Track: Personality Symposium - SY03 BIOMARKERS IN DUAL DISORDERS Magi Farré, Institut Hospital del Mar d'investigacions Mèdiques-IMIM, Universitat Autònoma de Barcelona, España. BIOMARKERS IN PSYCHIATRY: AN OVERVIEW Rocío Martín-Santos, Institute of Neurosciences, Hospital Clínic, IDIBAPS, CIBERSM, España. ARE CYTOKINES BIOLOGICAL MARKERS OF DUAL DIAGNOSIS? Fernando Rodriguez de Fonseca, Instituto IBIMA, Hospital Carlos Haya de Málaga, España. NEW BIOINFORMATIC TOOL FOR SUPPORTING BIOMARKERS IDENTIFICATION FOR PSYCHIATRIC DISORDERS: PSYGENET Laura Furlong, Institut Hospital del Mar d'investigacions Mèdiques. Barcelona, España. Symposium - SY04 DUAL DISORDERS IN KETAMINE ADDICTION Wai Kwong Tang, The Chinese University of Hong Kong, China. PSYCHIATRIC MORBIDITY IN KETAMINE USERS Wai Kwong Tang, The Chinese University of Hong Kong, China. THE DIFFERENTIAL ROLES OF PSYCHOSOCIAL RISKS BETWEEN KETAMINE USERS AND BETEL BUT CHEWERS IN TAIWAN Kun-Hua Lee, Kao Yuli Hospital, Ministry of Health and Welfare, Taiwan. Symposium - SY05 BIPOLARITY AND ADDICTIVE DISORDERS Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú. BIPOLARITY AND COCAINE TO THE BRAIN SPECT Agata Salazar, Universidad Peruana Cayetano Heredia. Lima, Perú. PREVALENCE AND BIPOLAR CLINIC Carlos Ordoñez, Hospital Hermilio Valdizan. Lima, Perú. DUAL DIAGNOSIS NEUROTOXIC THEORY Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú. Symposium - SY06 COGNITIVE NEUROSCIENCE APPLIED TO PERSONALITY DISORDERS AND PSYCHOPATHY www.cipd05.com Pág.
Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 6:00 7:30 Room 7 Track: Post-Traumatic Stress 6:00 6:45 Room 8 Track: Useful Psychotropic Drugs 6:45 7:30 Room 8 Track: Psychosis 6:00 7:30 Room 9 Track: Child & Adolescent Psychiatry Guillermo N. Jemar, Hospital Borda, Asociación Neuropsiquiátrica Argentina, Argentina. NEUROBIOLOGY OF ANTISOCIAL BEHAVIOR AND NEUROBIOLOGICAL APPROACHES TO PSYCHOPATHOLOGY Martin Mazzoglio y Nabar, Asociación Neuropsiquiátrica Argentina - Servicio Penitenciario Federal Argentina, Argentina. THE ETHICAL AND LEGAL ASPECTS IN PERSONALITY DISORDERS AND PSYCHOPATHY Ramiro Isla, Asociación Neuropsiquiátrica Argentina - Defensoría General de La Nación, Argentina. Symposium - SY07 LATEST DEVELOPMENTS IN SIMULTANEOUS TREATMENT OF TRAUMA AND ADDICTION Ayna Johansen, Norwegian Centre for Addiction Research, University of Oslo, Norway. CONCURRENT TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND ALCOHOL DEPENDENCE IN WOMEN IN A SWEDISH SETTING - A PILOT STUDY Anna Persson, Karolinska Institutet. Solna, Sweden. A RATIONALE FOR EMOTION-FOCUSED TREATMENT FOR COMORBID SUBSTANCE USE DISORDER AND POST-TRAUMATIC STRESS Shedeh Tavakoli, Northeastern Illinois University, Chicago. IL, USA. THERAPIST EXPERIENCES AND TRAINING NEEDS FOR TREATING SIMULTANEOUS TRAUMA AND ADDICTION Ingerid E. Bjelland, Frogn Kommune, Norway. Main Lecture - ML0 DRUGS AS MEDICATIONS IN DUAL DISORDERS Carlos Roncero, Universidad Autónoma de Barcelona, España. Speaker: Rafael Maldonado, Universidad Pompeu Fabra. Barcelona, España. Main Lecture - ML0 ARE EXISTING PSYCHIATRIC DIAGNOSES ABLE TO DESCRIBE DUAL DISORDERS IN THE LIGHT OF A WIDENING COMORBIDITY? José M. Goikolea, Hospital Clinic, Barcelona, España. Speaker: Pier Maria Furlan, Dept. of Mental Health and Drug Abuse, Turin, Italy. Symposium - SY08 ENHANCING CARE FOR ADOLESCENTS WITH DUAL DISORDERS: OUTREACH PREVENTION EFFORTS, PEDIATRIC HEALTH EVALUATIONS AND SUICIDAL RISK ASSESSMENT www.cipd05.com Pág. 3
Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA. CANNABIS HEALTH RISKS AND PREVENTION PROGRAMS Mònica Prat, Hospital Universitari Vall d'hebron. Barcelona, España. PEDIATRIC HEALTH EVALUATION Donald E. Greydanus, Western Michigan Univ. SchooloOf Medicine, Kalamazoo. MI, USA. SUICIDAL RISK ASSESSMENT Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA. 6:00 6:45 Room 0 Track: Multidisciplinary Intervention in Dual 6:45 7:30 Room 0 Track: Personality 6:00 6:45 Room Track: Training in Dual Diagnosis Workshop - WS0 ASSERTIVE OUTREACH SERVICES IN DUAL DISORDERS. STATE OF THE ART, AND THE NORWEGIAN SOLUTION IN COMMITTED, COMMUNITY COLLABORATION - THE C-FLEX MODEL Bror Just Andersen, Baerum DPC, Veste Viken HT, Norway. INTERDISCIPLINARY ASSERTIVE OUTREACH TEAMS IN DUAL DISORDERS - STATE OF THE ART Lars Linderoth, Vestre Viken HT/Baerum DPC, Norway. THE DEVELOPMENT, EXPERIENCE AND SUCCESS FACTORS WITH THE C-FLEX TEAM Kjetil Emilsen, Vestre Viken HT/Baerum DPC, Norway. THE WAY AHEAD - ESTABLISHING A C-FLEX YOUTH TEAM Aslak Woien Augedal, Vestre Viken HT/ Division of Mental Health And Addiction, Norway. METHODICAL APPROACH AND RESULTS OF THE EFFECT EVALUATION OF THE C-FLEX TEAM - THREE YEARS OF MODEL TESTING Bror Just Andersen, Baerum DPC, Veste Viken HT. Norway. Workshop - WS0 THE USE OF EAR ACUPUNCTURE TO AID IN RETENTION OF THOSE WITH BORDERLINE PERSONALITY DISORDER IN SUBSTANCE ABUSE TREATMENT Chair/Speaker: Elizabeth B. Stuyt, Colorado Mental Health Institute at Pueblo, Pueblo. CO, USA. Symposium SY09 PROTOCOLS OF INTERVENTION IN DUAL PATHOLOGY Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Carlos Roncero, Universidad Autónoma de Barcelona, España. José Martínez-Raga, Unidad de Conductas Adictivas de Gandía, CEU Cardenal Herrera. Valencia, España. www.cipd05.com Pág. 4
Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 6:45 7:30 Room 6:00 7:30 Room Special Lecture SL0 DUAL PATHOLOGY AND ART Co-organized by the Foundation on Dual Lara Grau-López, Hospital Universitari Vall d Hebron. Barcelona, España. Speaker: J. Ramon Pigem, Clínica Bellavista, Lleida, España. Oral Communications - OC0 Chairs: José Antonio Navarro, Hospital Universitario Vall d Hebron de Barcelona/Clínica Galatea. Barcelona, España. Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay. EXECUTIVE FUNCTIONING, SUICIDE ATTEMPTS AND SUBSTANCE RELAPSES IN PATIENTS WITH AND WITHOUT PSYCHIATRIC COMORBIDITY I. Benaiges, S. López-Vera J. E. Marquez-Arrico, G. Prat, A. Adan, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, España. Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España. CANNABIS: SU INFLUENCIA A LO LARGO DE UN AÑO EN LOS INTENTOS DE SUICIDIO M. Canal Rivero,, A. Yañez Castro, G. Benítez Rodriguez, J. García Egea, Jordi E. Obiols, M. Ruiz Veguilla,3 Hospital Universitario Virgen del Rocío. Sevilla, España. Facultat de Psicología. Departament de Psicología Clínica i de la Salut. Universitat Autònoma de Barcelona, España. 3 Instituto de Biomedicina de Sevilla (IBIS), España. PERSONALITY DISORDERS, SUBSTANCE USE DISORDER AND CRIMINAL BEHAVIOR Anna C. S. Chaves University of São Paulo, São Paulo, Brasil. PERIPHERAL TEMPERATURE CIRCADIAN RHYTHM IN PATIENTS WITH DUAL DIAGNOSIS: MENTAL DISORDER AS A MODULATING FACTOR S. López-Vera, I. Benaiges, J.A. Madrid, A. Adan,3 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, España. Chronobiology Laboratory, Department of Physiology, University of Murcia, España. 3 Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España. THE CO-MORBIDITY BETWEEN SUICIDE VICTIMS IN THE DISTRICT OF TIRANA, OVER THE TIME PERIOD 00-00 Pasho Maksuti, Vuksan Kola, Artan Simaku 3 UHC (University Hospital Centre) Mother Theresa, Tirana, Albania. www.cipd05.com Pág. 5
Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Institute of Public Health, Tirana, Albania. FOCUS GROUPS: A METHOD FOR DEVELOPING GUIDELINES FOR DUAL DIAGNOSIS F. Matthys, P. Joosten, W. van den Brink 3, B. Sabbe 4 University Hospital Brussels and Vrije Universiteit Brussels (VUB), The Netherlands. Psychiatric Centre Broeders Alexianen, Tienen, Belgium. 3 Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center,University of Amsterdam, Amsterdam, The Netherlands. 4 Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium. ADDICTION AND MENTAL PRODUCTIONS IN TRAUMATIC PATHOLOGIES Freddy nyegue, Mlle Laurine Fort Centre Psychothérapique de Laxou/ Nancy, France. Université de Lorraine, France. THE EFFECT OF ACADEMIC SELF-EFFICACY AND SELF-AWARENESS ON ACADEMIC ACHIEVEMENT IN STUDENTS WITH LEARNING DISABILITY (LD) Moluk Khademi Ashkezari, Salehe Piryaei Alzahra University, Tehran, Iran. 7:30-8:30 h. 7:30 8:30 Auditorium A Track: Opioid System and Dual Plenary Session - PS0 TREATMENT AND 4-MONTH FOLLOW-UP OF PRESCRIPTION OPIOID DEPENDENCE: THE ROLE OF DUAL DISORDERS Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d Hebron. Barcelona, España. Speaker: Roger Weiss, Harvard Medical School/division of Alcohol and Drug Abuse, McLean Hospital, Belmont. MA, USA. www.cipd05.com Pág. 6
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 h. 08:30 0:00 Auditorium A Track: Attention Deficit 08:30 0:00 Auditorium B Track: Spirituality and Dual 08:30 09:5 Room Track: Training in Dual Diagnosis 09:5 0:00 Room Track: Basic Research Symposium SY0 MANAGEMENT OF SUBSTANCE USE DISORDERS IN PATIENTS WITH ADHD Josep A. Ramos-Quiroga, Hospital Universitari Vall d'hebron. Barcelona, España. TREATMENT OF COCAINE DEPENDENCE IN ADULTS WITH ADHD Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. ADHD MEDICATION USE AND MISUSE IN ADOLESCENCE Geurt van de Glind, Amsterdam Institute for Addiction Research. Amsterdam, The Netherlands. TRAUMA IN SUD PATIENTS WITH AND WITHOUT ADHD Maija Konstenius, Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet. Solna, Sweden. IS THE METHYLXANTHINE'S CONSUMPTION INCREASED IN ADULTS WITH ADHD? Josep A. Ramos-Quiroga, Hospital Universitari Vall d'hebron. Barcelona, España. Debate Forum - DF0 TRASCENDENCE OF SPIRITUALITY AND DUAL DISORDERS Adolf Tobeña, Catedrático de Psiquiatría y Psicología Médica. Universitat Autònoma de Barcelona, España. SELF-HELP AND SPIRITUALITY Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. INTERVIEW ON SPIRITUALITY IN DUAL PATIENTS Jaime Roig, Centre Medic Alella. Barcelona, España. Main Lecture - ML03 DUAL DISORDERS IN THE JOURNAL ADDICTION Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. Speaker: Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. Main Lecture - ML04 DELAYED GRATIFICATIONS AND DUAL PATHOLOGIES: THE PRICE OF MODERNITY Joan Colom, Agència de Salut Pública de Catalunya, España. Speaker: Ruben Baler, National Institute on Drug Abuse, Bethesda. MD, USA. www.cipd05.com Pág. 7
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 Room -3 Track: Cannabis and Dual 08:30 0:00 Room 4 Track: Personality 08:30 0:00 Room 5 Track: Transcultural Psychiatry Invited Symposium - IS0 THE ONGOING DEBATE: CANNABIS AND DUAL DISORDERS Amine Benyamina, Centre d'enseignement, de Recherche et de Traitement des Addictions. Paris, France. CANNABIS ABUSE AND SHORT PSYCHOTIC EPISODES Mehdi Paes, Mohamed V Universityin Rabat, Morocco. CANNABIS USE IN CHRONIC SCHIZOPHRENIA PATIENTS Carmen Barral, Hospital Universitari Vall d'hebron. Barcelona, España. CANNABIS AND OTHER DRUGS: USE AMONG DUAL DISORDERS PATIENTS WITH PERSIST MENTAL ILLNESS. A 7 YEARS LONGITUDINAL FOLLOW-UP STUDY Kim T. Mueser, Boston University, USA. Symposium - SY RELEVANCE OF SUBSTANCE USE DISORDERS (SUD) IN A LONG LIFESPAN: PROGRAM OF TPL BARCELONA GROUP Marc Ferrer, Hospital Universitari Vall d'hebron. Barcelona, España. THE IMPORTANCE OF SUBSTANCE USE DISORDER IN A PROGRAM FOR THE BORDERLINE PERSONALITY DISORDER (BPD) THROUGHOUT LIFE Mercè Gibert, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. THE IMPORTANCE TO TREAT THE SUBSTANCES USE DISORDER COMORBIDITY Joan Vegué, Universitat Autònoma de Barcelona, Servei de Psiquiatria en Hospital Vall d'hebron. Barcelona, España SUBSTANCE USE DISORDERS (SUD) IN BORDERLINE PERSONALITY DISORDER (BPD): INFLUENCE AT CLINICAL MANIFESTATION Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. Invited Symposium - IS0 DUAL DISORDERS IN THE MODERN WORLD: TRANSCULTURAL APPROACH Dinesh Bhugra, King s College London, United Kingdom. CULTURAL INTERVIEW IN DUAL PATIENTS Francisco Collazos, Hospital Universitari Vall d'hebron, Barcelona, España. IMMIGRATION, SOCIAL PSYCHIATRY AND DUAL PATHOLOGY Dinesh Bhugra, King s College London, United Kingdom. IS DUAL DISORDER DIFFERENT IN LATIN POPULATIONS AMONG LATINOS IN USA? Margarita Alegria, Center for Multicultural Mental Health Research, Cambridge Health Alliance & Harvard Medical School, Somerville. MA, USA. www.cipd05.com Pág. 8
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 Room 6 Track: Multidisciplinary Intervention in Dual 08:30 0:00 Room 7 Track: Psychopharmacological Treatments in Dual 08:30 0:00 Room 8 Track: Psychotherapeutic Treatment in Dual Symposium - SY BIOLOGICAL RHYTHMS AND DUAL DISORDERS. A NON NEGLIGIBLE CONNECTION Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España. CHRONOBIOLOGY AND DUAL DISORDERS. THE CURRENT STATE OF KNOWLEDGE Sílvia López-Vera, Universitat de Barcelona. Barcelona, España. RHYTHMIC IMPAIRMENT AND MODULATING FACTORS IN PATIENTS WITH DUAL DIAGNOSIS Irina Benaiges, Universitat de Barcelona. Barcelona, España. CLINICAL IMPLICATIONS OF RHYTHMIC IMPAIRMENT IN SUBSTANCE USE DISORDERS AND DUAL DIAGNOSIS Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España. Debate Forum - DF03 DRUGS FOR USE IN CONDITIONS DIFFERENT TO THOSE AUTHORIZED IN DUAL DISORDERS: CONSENSUS OF THE SEPD Francisco J. Álvarez, Institute for The Study of Alcohol and Drugs, Universidad de Valladolid, España. CONSENSUS OF SEPD ON DUAL BIPOLAR DISORDER TREATMENT Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM. Valencia, España. CONSENSUS OF SEPD ON DUAL DISORDER ANXIETY TREATMENT Marisa Dorado, Unidad de Conductas Adictivas De Gandía. Valencia, España. CONSENSUS OF SEPD ON DUAL DISORDER DEPRESSION TREATMENT: PRELIMINARY PROPOSAL OF THE WORKING GROUP Pablo Vega, Instituto de Adicciones. Madrid, España. Debate Forum - DF04 HOW TO STOP THE TRAIN BEFORE IT CRUSHES OR DERAILS? ASSESSMENT AND PREVENTION OF DUAL PATHOLOGY IN ADOLESCENCE Rosa Fernández-Marcote, UCA de Toledo, Hospital Provincial, SESCAM. Toledo, España. EFFECTIVE PSYCHOLOGICAL INTERVENTIONS IN ADOLESCENTS WITH DUAL PATHOLOGY. FROM PREVENTION TO TREATMENT Lorena Casete, Unidad Asistencial de Drogodependencias. ACLAD. A Coruña, España. DUAL TEENS Raquel Vidal, Hospital Universitari Vall de Hebrón. Barcelona, España. WHAT ABOUT "OUR" TEENS? CODEPENDENCIES AND RISKS Angel M. Turbi, Universidad Católica de Valencia. S Vicente Mártir. Valencia, España. PSYCHOMETRIC EVALUATION TOOLS IN DUAL PATHOLOGY www.cipd05.com Pág. 9
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d Hebron, Barcelona, España. 08:30 0:00 Room 9 08:30 0:00 Room 0 Track: Alcohol 08:30 09:5 Room Track: Epidemiology and Dual 09:5-0:00 Room Track: Child & Adolescent Psychiatry Medical Educational Room Sponsored by the Foundation on Dual Symposium - SY3 NOVEL APPROACHES TO UNDERSTANDING AND TREATING COMORBID DEPRESSION AND ALCOHOL MISUSE Marie-Eve Couture, Dalhousie University. Halifax, Canada. A QUALITATIVE STUDY OF DRINKING TO COPE WITH DEPRESSION Marie-Eve Couture, Dalhousie University. Halifax, Canada. CONTEXT COUNTS: SOLITARY DRINKING EXPLAINS THE ASSOCIATION BETWEEN DEPRESSIVE SYMPTOMS AND ALCOHOL-RELATED PROBLEMS Matthew Keough, Concordia University. Montréal, Canada. THE EFFECTS OF DEPRESSION LEVEL AND ALCOHOL ADMINISTRATION ON POSITIVE AND NEGATIVE POST-EVENT RUMINATION: AN EXPERIMENTAL STUDY Sherry H. Stewart, Dalhousie University. Halifax, Canada. INTERVENING WITH HOPELESSNESS REDUCES AND PREVENTS DEPRESSION AND ALCOHOL MISUSE IN ADOLESCENTS Patricia Conrod, Université de Montréal, Canada. Main Lecture - ML05 CORMORBIDITY OF SUBSTANCE AND PSYCHIATRIC DISORDERS: EPIDEMIOLOGIC FINDINGS, NEW DIRECTIONS Pere Bonet, Pere Bonet Gabinet Psiquiatria i Psicologia Clínica, Manresa. Barcelona, España. Speaker: Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA. Workshop - WS03 ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL DISORDERS: DIFFERENTIAL DIAGNOSTIC CHARACTERISTICS Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. ADOPTED AND NON-ADOPTED ADOLESCENTS: CRITERIA FOR RESIDENTIAL ADMISSION TO SPECIALISED HEALTHCARE FACILITIES Ramon Martí, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED ADOLESCENTS AND www.cipd05.com Pág. 0
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 YOUNG ADULTS AT SPECIALISED HEALTHCARE CENTRES Cristina Baliarda, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. 08:30 0:00 Room Oral Communications - OC0 Chairs: Nicolás Ramírez, Hospital Sant Rafael, Barcelona, España. Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico. TIME TREND ANALYSIS OF PATIENTS WITH DUAL SEEKING TREATMENT FROM DUAL DIAGNOSIS CLINIC OF A TERTIARY CARE SUBSTANCE USE DISORDER TREATMENT CENTRE IN INDIA Y.P.S.Balhara, R. Gupta, R. Lal India Institute of Medical Sciences (AIIMS), New Delhi, India. PERPETRATOR OF FACTITIOUS DISORDER ON ANOTHER RECEIVES AN INTERNAL SELF- REWARD IN THE MEDICAL ENVIRONMENT. ADDICTIVE BEHAVIOR? M. López-Rico, J. López-Sánchez López J., J.L. Jiménez Hernández Facultad de Medicina. Universidad de Salamanca, España. Hospital "Doce de Octubre". Madrid, España. PSYCHIATRIC DISORDERS AND HIV-HCV COINFECTION: NEED FOR BETTER SCREENING AND CONTINUOUS CARE L. Michel, M. Winnock, C. Protopopescu 3, M.A. Loko, J.P. Lang 4, B. Spire 3, D. Salmon 5, F. Dabis 3, M.P. Carrieri 3 Centre Pierre Nicole; Inserm, U669, Paris, France. Inserm, U897, ISPED, Bordeaux, France. 3 Inserm, (SESSTIM), Marseille, France. 4 CHRU Strasbourg, Strasbourg, France. 5 Hôpital Cochin Port-Royal, Paris, France. A BROAD UNDERSTANDING OF GAMING ADDICTION: GAMERS THOUGHTS, PERCEPTIONS AND BEHAVIOURS IN GAME TRANSFER PHENOMENA A. Ortiz de Gortari, M.D Griffiths Nottingham Trent University, Nottingham, United Kingdom. DRUG AND SYMPTOMS OF PATHOLOGICAL GAMBLING IN COLOMBIAN PRISON POPULATION J. Ruíz Pérez, O. Garay Quevedo, L. Rueda Useche Facultad de Ciencias Humanas, Universidad Nacional de Colombia, Bogotá, Colombia. DETERMINE THE EFFECT OF TREATMENT ON RETENTION AMONG DRUG USERS Peymaneh Shirinbayan, Hassan Rafiey, Afshin Vejdani Roshan, Asghar dadkhah, Ali Farhoudian www.cipd05.com Pág.
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 University of Social welfare and rehabilitation sciences, Tehran, Iran. AUTISM SPECTRUM DISORDERS IN DUAL-DIAGNOSIS PATIENTS PREVALENCE STUDY CONDUCTED AT A DUAL DIAGNOSIS TREATMENT FACILITY A.E. Bonebakker, S. van Nieuwerk, R. Vuijk, P. Blanken 3 Palier Centre for Dual, The Hague, The Netherlands. Sarr Expertise Centre of expertise in autism, Rotterdam, The Netherlands. 3 Parnassia Addiction Research Centre, The Hague, The Netherlands. DSM-IV DIAGNOSES AMONG A COMMUNITY SAMPLE OF CHINESE ADOLESCENTS: RATES AND PATTERNS OF COMORBIDITY Patrick Leung The Chinese University Of Hong Kong, China. SYSTEMS OF CARE FOR DUAL DISORDERS: THE CANADIAN EXPERIENCE N. El-Guebaly University of Calgary, Alberta, Canada. 0:00 :00 h. 0:00 :00 Room 0:00 :00 Room -3 SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD 0:00 :00 Room 6 SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD :00 4:00 h. :00 4:00 Room :00 4:00 Room -3 :00 4:00 Room SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD Supported WORKSHOP Industry Session not included in official scientific programme CME/CPD www.cipd05.com Pág.
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 4:00 5:30 h. 4:00 5:30 Auditorium A Track: Tobacco 4:00 5:30 Auditorium B Track: Personality Invited Symposium - IS03 SMOKE IN YOUR EYES Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. DEPRESSION AND ADDICTION, DOES TOBACCO AFFECT Eugeni Bruguera, Hospital Universitari Vall d'hebron. Barcelona, España. TREATMENT OF TOBACCO DEPENDENCE AND ITS INFLUENCE ON OTHER ADDICTIONS Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. CHOLINERGIC SYSTEM AND TOBACCO AND DUAL DISORDERS Manuel Gurpegui, Universidad de Granada, España. Debate Forum - DF05 PERSONALITY FEATURES OR PERSONALITY DISORDERS: DOES IT MATTER IN DUAL DISORDERS? Jose L. Carrasco, Universidad Complutense de Madrid, España. THERAPEUTIC STRATEGIES OF SUBSTANCE USE DISORDER WITH COMORBIDITY OF BORDERLINE PERSONALITY DISORDER Miquel Gasol, Psiquiatría y Psicología del Hospital General de Catalunya. Barcelona, España. TRAITS, TROUBLES AND SUBSTANCE USE Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàtel, Switzerland. THE IMPORTANCE OF (SUBSTANCE USE DISORDER) SUD IN THE COMPLEX PATHOGENESIS OF (BORDERLINE PERSONALITY DISORDER) BPD Marc Ferrer, Hospital Universitari Vall d'hebron. Barcelona, España. 4:00 5:30 Room Track: Basic Research Invited Symposium - IS04 ARE GENETICS RISK FACTORS FOR DUAL DISORDERS? Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA. CANNABIS USE AND SCHIZOPHRENIA FROM THE PERSPECTIVE OF THE GENETIC FACTORS Araceli Rosa, Universidad de Barcelona, España. GENETIC RISK FACTORS FOR DRUG ADDICTION Noelia Fernández, Genetics Department, UB. CIBERER. Barcelona, Spain. POLYMORPHISMS AND THE EFFICACY OF METHADONE Francina Fonseca, Hospital del Mar. Barcelona, España. www.cipd05.com Pág. 3
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 4:00 5:30 Room -3 Track: Cannabis and Dual Invited Symposium - IS05 CANNABIS, PSYCHOSIS AND DUAL DISORDERS Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. FIRST PSYCHOTIC EPISODES; CANNABIS AND DUAL PATHOLOGY Luis San, Hospital Sant Joan de Deu. Barcelona, España. EVALUATION OF CANNABIS CONSUMPTION IN PSYCHOTIC DUAL PATIENTS Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. USE OF CANNABIS AND ITS INFLUENCE IN ON DEVELOPMENT Miguel Ruiz-Veguilla, Hospital Virgen del Rocío. Sevilla, España. 4:00 5:30 Room 4 Track: Training in Dual Diagnosis 4:00 5:30 Room 5 Track: Evaluation processes in Dual 4:00 5:30 Room 6 Track: Psychosis Symposium SY4 THE CONVERGENCE OF ADDICTION MEDICINE AND DUAL DISORDERS Session in collaboration with ISAM, ACAPI and SEPD Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA. Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Nady El-Guebaly, University of Calgary. Alberta, Canada. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Symposium - SY5 NEUROPSYCHOLOGICAL PERFORMANCE ON DUAL DISORDERS Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España. NEUROPSYCHOLOGICAL IMPACT OF DUAL DISORDERS. CURRENT KNOWLEDGE Gemma Prat, Universitat de Barcelona, España. NEUROPSYCHOLOGICAL ASSESSMENT IN DUAL DISORDER PATIENTS. SELECTING TASKS TO OPTIMIZE THE EVALUATION Carlos Jacas, Hospital Universitari Vall d'hebron. Barcelona, España. NEUROCOGNITIVE PERFORMANCE OF DUAL SCHIZOPHRENIA: A POSSIBLE BIOMARKER Irina Benaiges, Universitat de Barcelona, España. Symposium SY6 FETAL ALCOHOL SPECTRUM DISORDER AS A GENERATOR OF DUAL PATHOLOGY Montse Pàmias, Corporació Sanitaria I Unviersitari Parc Taulí, Sabadell. Barcelona, España. EAF: EPIDEMIOLOGY AND A SKI CLINIC Anna Sans, Hospital Sant Joan de Déu D' Esplugues. Barcelona, España. www.cipd05.com Pág. 4
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 NEUROPSYCHOLOGY AND LEARNING IN THE EAF Natália Picó, Fundació Institut de Psicologia. Barcelona, España. PSYCHIATRIC COMORBIDITY IN THE EAF Núria Gómez, Hospital Universitari Vall d Hebron. Barcelona, España. 4:00 5:30 Room 7 Track: Alcohol 4:00 5:30 Room 8 Track: Psychotherapeutic Treatment in Dual 4:00 5:30 Room 9 4:00 5:30 Room 0 Track: Transcultural Psychiatry Symposium - SY7 ALCOHOL AND AGRESSION: AN INTIMATE RELATIONSHIP! Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL AND SEXUAL ASSAULT Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL AND AGRESSION - VICTIMS AND THE SNOWBALL EFFECT Tânia Abreu, Centro Hospitalar Tamega E Sousa. Penafiel, Portugal. ALCOHOL, SEVERE MENTAL ILLNESS AND AGRESSION Catarina Freitas, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL, ANTISOCIAL PERSONALITY AND AGRESSION Teresa Sousa-Ferreira, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. Debate Forum - DF06 EFFECTIVENESS OF PSYCHOLOGICAL TREATMENTS IN DUAL PATHOLOGY AND ADEQUACY OF RESOURCES. HAVE WE CHANGED ONE ADDICTION FOR ANOTHER? Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España. PSYCHOLOGICAL INTERVENTION IN DUAL PATHOLOGY: AN INTEGRATED NETWORK MODEL OF SOCIAL AND HEALTH RESOURCES IN THE CITY OF BARCELONA Cristo M. Cruz, Centre d'atenció i Seguiment Sarrià. Barcelona, España. TREATMENT, EFFICACY AND THE FIGURE OF THE PSYCHOTHERAPIST Mª Elena Bernal, Servicio Provincial de Drogodependencias de la Diputación de Almería, España. PSYCHOTHERAPIES IN DUAL PATHOLOGY Diana Kushner, Universidad de Santiago de Chile. Santiago, Chile. EVOLUTION OF TREATMENT PROGRAMS IN DUAL PATHOLOGY Abel Baquero, PPDG Consorcio Hospitalario Provincial de Castellón. Comunidad Valenciana, España. Medical Educational Room Sponsored by the Foundation on Dual Symposium - SY8 IDENTIFYING STRATEGIES FOR IMPROVING CARE FOR LATINO IMMIGRANTS WITH DUAL DISORDERS IN SPAIN AND THE U.S.: RESULTS FROM THE INTERNATIONAL LATINO RESEARCH PARTNERSHIP www.cipd05.com Pág. 5
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Margarita Alegria, Harvard Medical School, Somerville. MA, USA. COMPARISON OF MENTAL HEALTH TREATMENT EXPENDITURES AMONG PATIENTS WITH DUAL DISORDERS IN USUAL PSYCHIATRIC CARE BETWEEN MADRID AND BOSTON HOSPITAL SYSTEMS Rodrigo Carmona, Fundación Jiménez Diaz. Madrid, España. AN INTERNATIONAL COMPARISON OF EPISODES OF SUBSTANCE ABUSE TREATMENT AMONG NATIVE-BORN AND LATINO IMMIGRANTS IN PUBLIC HOSPITAL SETTINGS IN BARCELONA AND BOSTON Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. COMMONALITIES AND DIFFERENCES IN BEHAVIORAL HEALTH CARE FOR LATINO POPULATIONS IN PRIMARY CARE Daniel Gonzalez, Cambridge Health Alliance, Somerville. MA, USA. THE TESTING OF THE AC-OK WITH AN INTERNATIONAL SAMPLE OF LATINO IMMIGRANTS Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico. 4:00 4:45 Room Track: Child & Adolescent Psychiatry 4:45 5:30 Room Track: Personality Workshop - WS04 ADDICTIONS AND DUAL DISORDERS IN JUVENILE JUSTICE Rosa de Sta. Mª Pérez, Parc Sanitari Sant Joan de Deu. Barcelona, España. MENTAL HEALTH CARE AND SUBSTANCE ABUSE IN YOUNG OFFENDERS: AN INTEGRATIVE APPROACH TO HEALTH CARE IN THE FIELD OF JUVENILE JUSTICE IN SPAIN Jorge M. Garcia, Hospital Punta de Europa de Algeciras. Cádiz, España. VULNERABILITY AND DUAL PATHOLOGY IN YOUNG OFFENDERS Jaume Martinez, Unitat Terapéutica de Justica Juvenil Els Til lers. Barcelona, España. SPECIFICS OF THE MANAGEMENT AND TREATMENT OF DUAL PATHOLOGY IN TEENAGERS WITH MANY PROBLEMATIC QUESTIONS Jaume Claramunt, Parc Sanitari Sant Joan de Deu. Barcelona, España. Workshop - WS05 ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE PERSONALITY DISORDER Maite Utges, Hospital Santa Maria. Lleida, España. THE ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE PERSONALITY DISORDER, A DANGEROUS COMBINATION Maite Utges, Hospital Santa Maria. Lleida, España. APPROPRIATE USE OF INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS) IN THE TREATMENT OF BORDERLINE PERSONALITY DISORDER (BPD) Enrique Díaz, Hospital de Santa María, Lleida, España. 4:00 5:30 Oral Communications - OC03 www.cipd05.com Pág. 6
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Room Chairs: José M. Goikolea, Hospital Clinic, Barcelona, España. Pier P. Pani, Social-Health Services, Health District 8, Cagliari, Italy. FORENSIC PSYCHIATRIC SERVICES IN THE ARAB WORLD, THE PAST AND THE FUTURE Hasanen Al-Taiar, Saif Al-Hashimi, Moustafa Hussien Soltan 3 Oxford Health NHS Foundation Trust, United Kingdom. Armed Forces Hospital. Muscat, Oman. 3 Egypt. ABUSE OF VIDEO GAMES AND THE INTERNET IN A CASE OF AUTISM R. Cappai, S. Marras, I. Obbili Studio di Psicologia, Costruttivamente. Cagliari, Italy. AN EXPLORATORY ONLINE SURVEY ON THE PREVALENCE OF HYPERSEXUAL BEHAVIOUR R. Gupta, D. Deka, YPS. Balhara All India Institute of Medical Sciences, New Delhi, India. LIMES, LIMEN. BORDERLINE PERSONALITY DISORDER AND SUBSTANCES ABUSE: TWO LINKED PATHOLOGIES ON THE BORDER BETWEEN NEUROLOGY AND PSYCHIATRY, LAW AND CLINIC Marco Mollica, Veronica Aiello DINOGMI, Section of Psychiatry, University of Genoa, San Martino Hospital, Largo Rosanna Benzi, Genoa, Liguria, Italy. FEATURES AND PERMANENCE IN TREATMENT OF A SAMPLE OF DRUG USERS LEGALLY CONDITIONED TO TAKE TREATMENT IN CENTERS OF YOUTH INTEGRATION TLALPAN C. Tejeda Romero, DB Díaz Negrete Centros de Integración, Tlalpan, DF, México. Centros de Integración Juvenil, DF, México. BUILDING AN INDIVIDUALIZED PROFILE FOR TREATMENT ACROSS BEHAVIORAL ADDICTIONS N. el-guebaly. University of Calgary, Alberta, Canada. Alberta Gambling Research Institute, Alberta, Canada. NURSING INTERVENTION IN DRUG ADDICTION CENTERS (CAD) PROTOCOL S. Gutiérrez Cáceres, J. Chicharro Romero, M. Sáez García 3, D. Coca Pérez 4, J. Martín Herrero 5, N. García Hidalgo 6, N. Salgado Marcos 6, C. López Jiménez 5, A. Vicente Partido 7, C. Culebras García 5 DUE CAD Latina, Madrid, España. DUE CAD San Blas, Madrid, España. 3 DUE CAD Hortaleza, Madrid, España. 4 DUE CAD Tetuan, Madrid, España. www.cipd05.com Pág. 7
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 5 DUE CAD Arganzuela, Madrid, España. 6 DUE CAD Vallecas, Madrid, España. 7 DUE CAD Villaverde, Madrid, España. 5:30 7:00 h. 5:30 7:00 Room Track: Psychosis 5:30 7:00 Room -3 Track: Cannabis and Dual 5:30 7:00 Room 4 Track: Training Dual Diagnosis Symposium SY9 ARE THERE CLINICAL-NEUROBIOLOGICAL DIFFERENCES BETWEEN CANNABIS USERS WITH PSYCHOSIS AND NON-USERS WITH PSYCHOSIS? Francisco Arias, Hospital Doce de Octubre. Madrid, España. GENETIC VULNERABILITY TO PSYCHOSIS IN CANNABIS USERS AND NON-USERS Francisco Arias, Hospital Doce de Octubre. Madrid, España. CLINICAL AND PREPULSE INHIBITION DEFICIT DIFFERENCES BETWEEN CANNABIS-INDUCED PSYCHOTIC DISORDER AND SCHIZOPHRENIA Gabriel Rubio, Universidad Complutense de Madrid. Madrid, España. DIFFERENCES IN TREATMENT AND EVOLUTION BETWEEN CANNABIS USERS AND NON- USERS AFTER STARTING THE FIRST PSYCHOTIC EPISODE PROGRAMME CARRIED OUT AT THE TH OCTOBER HOSPITAL, MADRID. Isabel Martínez, Hospital Doce de Octubre. Madrid, España. Debate Forum - DF07 CANNABIS: NEW INTERNATIONAL REGULATION. WHAT IS THE RISK IN DUAL DISORDERS? Manuel Mas-Bagá, CAT Barcelona, España. NEW POLITICS ABOUT CANNABIS: AN OPORTUNITY IN PUBLIC HEALTH? Joan Colom, Agència de Salut Pública de Catalunya, BarcOC0elona, España. CANNABIS USE IN THE USA Ruben Baler, National Institute on Drug Abuse. MD, USA. LEGALIZATION OF THE USE OF CANNABIS Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay. Invited Symposium IS06 WHERE ARE DUAL DISORDERS IN DSM5? Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España. SUBSTANCE-RELATED AND ADDICTIVE DISORDERS IN DSM-5: WHAT'S NEW? Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France. DUAL DISORDERS IN DSM-5: AN OVERVIEW Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA. SOME EXAMPLES OF COMORBIDITY WITH SUD IN DSM-5 www.cipd05.com Pág. 8
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. 5:30 7:00 Room 5 Track: Penitentiary (Prisons) & Dual Pathology 5:30 7:00 Room 6 Track: Evaluation processes in Dual 5:30 7:00 Room 7 Track: Alcohol 5:30 7:00 Room 8 Symposium - SY0 REHAB PROJECT AND OTHER DUAL DISORDERS APPROACHES IN EUROPEAN PRISONS Fabio Sternberg, Federación Europea de Sanidad Penitenciaria. Barcelona, España. DUAL DISORDERS APPROACH IN SPANISH PRISONS José M. Antolín, Sociedad Española de Sanidad Penitenciaria (SESP). Barcelona, España. DUAL DISORDERS APPROACH IN FRENCH PRISONS Fadi Meroueh, Asociación de Profesionales Sanitarios en Prisión (APSEP), Francia. Cyril Manzanares, Servicios Médicos de la Prisión Villeneuve Les Maguelone - CHU Montpellier, France. REHAB PROJECT AS AN APPROACH IN DUAL DISORDERS IN PRISON. THE VITERBO-ITALY EXPERIENCE Roberto Monarca, Sociedad Italiana de Medicina y Sanidad Penitenciaria (SIMSPe), Italy. Symposium - SY OUTCOME MEASURES IN HEROIN ADDICTED PATIENTS WITH DUAL DISORDERS TREATED WITH OPIOID AGONIST MEDICATIONS Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. INCREASING IMPORTANCE OF MEASURING OUTCOMES IN OPIOID DEPENDENCE CARE Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. STUDYING PSYCHOPATHOLOGY OF HEROIN ADDICTS AS OUTCOME MEASURES Pier P. Pani, Social-Health Services, Health District 8 (ASL 8) Cagliari, Italy. QUALITY OF LIFE AND CRAVING BEHAVIOUR AS OUTCOME MEASURES IN HEROIN ADDICTS Angelo G.I. Maremmani, University of Pisa. Pisa, Italy. Symposium - SY ALCOHOL CONSUMPTION DURING ADOLESCENCE AS A VULNERABILITY FACTOR IN DUAL DISORDERS Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. DELETERIOUS EFFECTS OF ALCOHOL CONSUMPTION DURING CRITICAL PERIODS OF LIFE Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. ETHANOL, STRESS AND ADOLESCENCE Marta Rodríguez-Árias, Universidad de Valencia. Comunidad Valenciana, España. NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY MATERNAL SEPARATION AND VULNERABILITY TO ALCOHOL CONSUMPTION IN MICE Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. ADDICTION RESEARCH AND HUMAN PHARMACOLOGY GROUPS, NEUROSCIENCES RESEARCH PROGRAM, IMIM Francina Fonseca, Hospital del Mar. Barcelona, España. Debate Forum - DF08 MULTIDISCIPLINARITY IN DUAL PATHOLOGY AND ITS KEYS: PSYCHOLOGICAL www.cipd05.com Pág. 9
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Track: Psychotherapeutic Treatment in Dual 5:30 7:00 Room 9 5:30 7:00 Room 0 Track: Attention Deficit 5:30 6:5 Room Track: Transcultural Psychiatry INTERVENTION José A. Carrobles, Universidad Autónoma de Madrid, España. TRANSDIAGNOSIS AND DUAL PATHOLOGY José A. Carrobles, Universidad Autónoma de Madrid, España. ROLE OF THE PSYCHOLOGIST: THE NEED TO INTEGRATE THE DISCIPLINE IN DUAL PATHOLOGY Mª Nieves Gómez, Ayuntamiento San Sebastian de Los Reyes, Madrid, España. THE ROLE OF THE PSYCHOLOGIST IN DUAL PATHOLOGY IN AN INTERDISCIPLINARY ADDICTIONS CARE TEAM Marcela Coromina, Centre d'atenció i Seguiment Sarrià, Centre d'atenció i Seguiment Baluard. Barcelona, España. Medical Educational Room Sponsored by the Foundation on Dual Symposium SY3 ADDICTIVE DISORDERS IN ADHD PATIENTS: A SELF-MEDICATION PROBLEM? Jorge Jaber, Clínica Jorge Jaber. Rio de Janeiro, Brasil. ADDICTIVE DISORDERS IN ADHA PATIENTS José Temótio, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. NEUROBIOLOGY OF ADHA AND ADDICTIVE DISORDERS Eugenio H. Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil. SELF-MEDICATION HYPOTHESIS IN ADDICTIVE DISORDERS IN ADHA PATIENTS Célia Franco, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. Workshop - WS06 BETWEEN EAST AND WEST: CHALLENGES IN TREATMENT OF PATIENTS WITH DUAL DISORDERS Andrej Kastelic, Center for Treatment of Drug Addiction, University Psychiatric Hospital Ljubljana, Slovenia. ARE THEY (WE) DIFFERENT? Nusa Segrec, Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana, Slovenia. BREAKING BARRIERS FOR TREATMENT OF DRUG USERS WITH DUAL DIAGNOSES WITH AIM TO IMPROVE THE ACCESS AND QUALITY OF TREATMENT Ljiljana Ignjatova, Psychiatric Hospital Skopje. Skopje, Macedonia. HOW STIGMA WILL DELAY A TREATMENT Luis Patricio, Casa de Saude De Carnaxide. Carnaixade, Portugal. www.cipd05.com Pág. 0
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 TREATING PEOPLE WITH MENTAL HEALTH PROBLEMS AND ADDICTION IN CLOSED SETTINGS Andrej Kastelic, Center for Treatment Of Drug Addiction, University Psychiatric Hospital Ljubljana, Slovenia. 6:5-7:00 Room Track: Gender and Dual Diagnosis 5:30 7:00 Room Workshop - WS07 TREATMENT OF CHALLENGING BEHAVIOURS IN HIGH FUNCTIONING WOMEN WITH AUTISM SPECTRUM DISORDER AND DUAL DISORDER Patricia J.M. van Wijngaarden-Cremers, Dimence Mental Health. Deventer, The Netherlands. Patricia J.M. van Wijngaarden-Cremers, Dimence Mental Health. Deventer, The Netherlands. Rutger Jan van der Gaag, Radboud University Medical Centre, Royal Dutch Medical Association. Utrecht, The Netherlands. Oral Communications - OC04 Chairs: Carmen Barral, Hospital Universitari Vall d'hebron. Barcelona, España. Edgard Belfort, Hospital Psiquiátrico de Venezuela, Caracas, Venezuela. FAMILY HISTORY OF SUBSTANCE ABUSE AND ITS IMPACT ON PSYCHOSOCIAL SKILLS PROGRAMS TO PREVENT SCHOOL VIOLENCE IN TEGUCIGALPA, HONDURAS Edwing Octavio Garcia Toro Facultad de Ciencias Médicas Universidad Nacional Autónoma de Honduras. Honduras. TAKING THE PLUNGE- A QUALITATIVE STUDY OF HOPE WITHIN THE MENTAL HEALTH AND SUBSTANCE ABUSE SERVICES Knut Tore Sælør, Ottar Ness, Randi Semb Buskerud and Vestfold University College, Drammen, Norway. COMPARATIVE STUDY OF UNIVERSITY STUDENTS, SONS OF ALCOHOLICS IN PUERTO RICO AND COSTA RICA J. Serra, A. Villafañe, M. Jiménez, W. Jiménez Universidad de Puerto Rico, San Juan, Puerto Rico. SEX ADDICTION : PSYCHIATRIC AND PSYCHOTHERAPEUTIC PERSPECTIVES Feldman Nelson, Sophia Ahab, Rodolphe Soulignac, Yasser Khazaal, Daniele Zullino Service d Addictologie, Département de santé mentale et psychiatrie, University Hospital of Geneva HUG, Switzerland. COCAINE IMPAIRS CELL GENESIS DURING ADOLESCENCE: IMPLICATIONS FOR DEPRESSION- LIKE BEHAVIOR IN ADULTHOOD M.J. García-Fuster, R. García-Cabrerizo, B. Keller University of the Balearic Islands, Palma de Mallorca, España. www.cipd05.com Pág.
Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 QUALITY OF LIFE OF MEN WITH ALCOHOL DEPENDENCE SYNDROME I. Linnuste,, K. Lang Foundation Pärnu Hospital, Pärnu, Estonia. University of Tartu, Tartu, Estonia. THE ROLE OF FAITH, SPIRITUALITY AND RELIGION IN THE PROCESS OF RECOVERY FROM DUAL DISORDERS Susana E. Mendez Enterhealth, Residential and Outpatient Services. Dallas, TE, USA. IMPLEMENTATION OF AN INTEGRATED CARE PATHWAY FOR CONCURRENT MAJOR DEPRESSIVE DISORDER AND ALCOHOL DEPENDENCE A.V.Samokhvalov,, J.A.Irving, S.Awan, B. Le Foll,, P.Voore, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. THE PREVALENCE OF MENTAL DISORDERS AMONG LESBIAN, GAY, BISEXUAL AND TRANSGENDER (LGBT) IN BAGHDAD Aziz Salim Shakir Fibms Iraqi Ministry of Health, Iraq. 7:00-9:00 h. 7:00 7:30 Auditorium 7:30 9:00 Auditorium Track: Multidisciplinary Intervention in Dual 9:00 0:30 Auditorium OPENING CEREMONY Plenary Session - PS0 BRAIN ADDICTIVE CIRCUITS ARE COMMON TO OTHER MENTAL ILLNESSES Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Speaker: Nora Volkow, National Institute on Drug Abuse (NIDA), Bethesda. MD, USA. NETWORKING EVENING www.cipd05.com Pág.
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 h. 08:30 0:00 Auditorium A Track: Attention Deficit 08:30 09:5 Room Track: Opioid System and Dual 09:5 0:00 Room Track: Attention Deficit 08:30 0:00 Room -3 Track: Spirituality and Dual 08:30 0:00 Room 4 Track: Cannabis and Dual Symposium SY4 DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN DUAL ADHD Salvador Ros, Hospital del Mar. Universidad Autónoma de Barcelona, España. ADHD AND SUBSTANCE USE DISORDER Juan Ramirez, Servicio Provincial Drogodependencias y Adicciones Huelva. España. ADHD AND BEHAVIORAL ADDICTIONS Juncal Sevilla, Universidad Autónoma de Madrid, Fundación Jimenez Díaz. Madrid, España. NEW CHALLENGES IN TREATMENT OF DUAL ADHD Andres Fontalba, Centro Salud Mental de Distrito, Huercal-Olvera. Huelva, España. Main Lecture - ML06 ROLE OF KAPPA OPIOID RECEPTORS IN THE TREATMENT OF DUAL PATHOLOGY Julio Bobes, Universidad de Oviedo, España. Speaker: Iván Montoya, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, USA. Main Lecture - ML07 REVISTING OLD CONCEPTS ON ADULT ADHD Luis Alfonzo B., Organización Panamericana de la salud. Washington, USA. Speaker: Luis A. Rohde, Federal University of Rio Grando do Sul, Department of Psychiatry, Porto Alegre, Brasil. Symposium - SY5 DUAL DISORDERS AND FREE WILL Célia Franco, Centro Hospitalar Universitário de Coimbra, Portugal. DUAL DISORDERS AND FREE WILL. WHAT IS HAPPENING? Luiz C. Coronel, Centro de Estudios Jose de Barros Falcão. Porto Alegre, Brasil. DUAL PATHOLOGY AND MENTAL COMPETENCES, WHAT CHANGES? Alfredo Calcedo, Universidad Complutense de Madrid. Madrid, España. Symposium - SY6 POTENTIAL THERAPEUTIC USE OF CANNABINOID RECEPTORS AND PHYTOCANNABINOIDS IN DUAL PATHOLOGY www.cipd05.com Pág. 3
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. THERAPEUTIC PERSPECTIVES OF CANNABIDIOL (CBD) IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. RELEVANCE OF THE REGULATION OF CANNABINOID SYSTEM IN DUAL PATHOLOGY Mª Salud García, Instituto de Neurociencias, Universidad Miguel Hernández. Alicante, España. ROLE OF CANNABINOID CB RECEPTOR IN DRUG ADDICTION AND DUAL PATHOLOGY Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. 08:30 0:00 Room 5 Track: Opioid System and Dual 08:30 0:00 Room 6 08:30 0:00 Room 7 Track: Psychoestimulants Symposium - SY7 RESPONSE PREDICTION IN HEROIN-ASSISTED TREATMENT: THE ROLE OF DUAL DISORDERS Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. COMORBID COCAINE DEPENDENCE IN HEROINE-ASSISTED TREATMENT: PREDICTING OUTCOME A TREATING POLYDRUG ADDICTION Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. OUTCOMES FOR PSYCHIATRIC COMORBIDITY IN HEROIN ASSISTED TREATMENT: PREDICTIVE FACTORS Teodora Groshkova, Centre for Health Evaluation & Outcome Sciences, Providence Health Care, Canada. RESPONSE TO INJECTABLE OPIOID TREATMENT IN PARTICIPANTS WITH MODERATE VS. LOW PSYCHOPATHOLOGY SYMPTOMS David C. Marsh, Northern Ontario School of Medicine, Canada. Debate Forum - DF09 WADD By invitation only Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine University of Miami. FL, USA. Co-chairs: Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d Hebron. Barcelona, España. Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Invited Symposium IS07 THE OLD COUPLE: COCAINE AND PSYCHOSIS Carlos Roncero, Universidad Autónoma de Barcelona, España. www.cipd05.com Pág. 4
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 GENETIC FEATURES OF COCAINE INDUCED PSYCHOSIS Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA. EPIDEMIOLOGY OF COCAINE INDUCED PSYCHOSIS Florence Vorspan, Publique-Hôpitaux de Paris, France. PSYCHOPATHOLOGICAL DIFFERENCES BETWEEN COCAINE-INDUCED PSYCHOSIS AND INDEPENDENT PSYCHOSIS IN COCAINE USERS Francisco González-Saiz, Unidad de Salud Mental Comunitaria, Hospital de Jerez, España. 08:30 0:00 Room 8 Track: Behavioral addictions / Gambling 08:30 0:00 Room 9 08:30 0:00 Room 0 Track: Planning, regulations and resource management 08:30 0:00 Room Track: Impulsivity Symposium SY8 EMOTIONAL DEPENDENCE: A NEW ADDICTION WITHIN THE FRAMEWORK OF DUAL DISORDERS? Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. EMOTIONAL DEPENDENCE VERSUS LOVE ADDICTION Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia, España. GENDER VIOLENCE AND EMOTIONAL DEPENDENCY Leticia Camarillo, Hospital General Universitario Gregorio Marañón. Madrid, España. Medical Educational Room Sponsored by the Foundation on Dual Symposium SY9 ORGANIZATION AND RESOURCES FOR DUAL DISORDERS ASSISTANCE Luis Caballero, Hospital Universitario Puerta de Hierro. Madrid, España. ORGANIZATION AND RESOURCES FOR DUAL DIAGNOSIS UNIT IN A MENTAL HOSPITAL IN LATIN AMERICA IN THE LAST CENTURY Elvia Velásquez, Alad (Latinoamerican Association On Addiction), Colombia. RESOURCES AND ORGANIZATION FOR DUAL PATHOLOGY ASSISTANCE IN ITALY Massimo Clerici, Universidad di Milano. Milano, Italy. Invited Symposium - IS08 IMPULSIVITY: A KEY SYMPTOM OR A KEY TREAT IN DUAL DISORDERS? Rodrigo Cordoba, Grupo CISNE, Bogotá, Colombia. DUAL PATHOLOGY AND COMPULSIVE IN-TAKES Gabriel Rubio, Universidad Complutense de Madrid, España. INFLUENCE OF IMPULSIVITY IN SUICIDE ATTEMPTS, DRIVING ACCIDENTS AND SEVERITY OF ADDICTIONS www.cipd05.com Pág. 5
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Laia Rodríguez-Cintas, CAS Vall d'hebron, Hospital Universitari Vall d'hebron. Barcelona, España. INFLUENCE OF IMPULSIVITY IN DUAL ADHD Eugenio Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil. 08:30 0:00 Room Oral Communications - OC05 Chairs: Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España. Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland. LOW-DEMAND TREATMENT IN DUAL DISORDERS R. Fernández López, P. Sanz Asín,, A. Bruguera Guitart,3, D. Aránega Guizán, M. Coromina Gimferrer,3, S. Martí Climent, G. López Cano, M.T. Bello Mayoraz CAS Baluard, Barcelona, España. CAS Sants, Barcelona, España. 3 CAS Sarrià, Barcelona, España. ABORDAJE Y MANEJO DE LA DINÁMICA FAMILIAR EN LA PATOLOGÍA DUAL Lucas García Thuring, Mª Nieves Gómez Llano, Soledad Marzo Pons 3 CTD El ALba. JCCM. España. Ayuntamiento San Sebastian de los Reyes. Madrid, España. 3 Ayuntamiento de Madrid. España. THE EFFECT OF PRESCRIBING METHADONE ON CHANGING OF MOODS IN OPIUM ADDICTS Alireza Homayouni, Seyed Jalal Mosavi Amiri, Arsalan KhanmohammadiOtaghsara 3, Gholamali Nikpour 4 College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran. Medical Clinic of Dr. Mosavi, Amirkola, Iran. 3 College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran. 4 Allameh Tabatabaii University, Tehran, Iran. ADDICTION, TRAUMA, MENTAL ILLNESS- TREATMENT OPTIONS FOR COMPLEX CONCURRENT DISORDERS Reinhard Michael Krausz University of British Columbia (UBC). NY, USA. MULTIDISCIPLINARY RESIDENTIAL INTERVENTION IN DUAL DISORDER E. Muscas, G. Trincas, P. Pili, G. Sanna, G. Grillo Casa Emmaus, Iglesias, Italia. A TRANSDIAGNOSTIC THERAPY FOR BEHAVIORAL DYSREGULATION: MINDFULNESS AND MODIFICATION THERAPY CUSTOMIZED FOR ALCOHOL USE, DRUG USE, AND ANGER ISSUES P. Wupperman,, A.L. Reed, E. Edwards, R. Shapiro, Q. Li, F. Unachukwa, B. Ryan John Jay College/City University of New York, New York, New York, USA. www.cipd05.com Pág. 6
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Yale University Medical Center, New Haven, Connecticut, USA. A DRUG TREATMENT PROGRAM FOR YOUNG ISRAELI BACKPACKERS WHO SUFFER FROM DUAL DIAGNOSIS Hagit Bonny-Noach, Haim Mell Ariel University & Beit Berl Academic College- Israel. Consultant, Israel Anti- Drug Authority (IADA). Board Member- Israeli society of Addiction Medicine(ILSAM), Israel. Head, Treatment & Rehabilitation Division, Israel Anti-Drug Authority, Israel. HOSPITALISATION OF SERVICE USERS BEFORE AND AFTER ADMISSION TO ASSERTIVE COMMUNITY TREATMENT IN NORWAY DOES SUBSTANCE USE MATTER? H. Clausen, T. Ruud, K.S. Heiervang, S. Odden, H.K. Stuen, A. Landheim Akershus University Hospital, Lørenskog, Norway. National Centre for Dual Diagnosis, Innlandet Hospital Trust, Hamar, Norway. NALMEFENE IN ALCOHOL USE DISORDER: A PRELIMINARY STUDY L.A. Núñez Domínguez, M García Nicolás, O Arbeo Ruiz 3 Centro Médico, Pamplona, Navarra, España. Mental Health Center, Tudela, Navarra, España. 3 Centro de Día Zuría, Pamplona, Navarra, España. 0:00 :00 h. 0:00 :00 Room 0:00 :00 Room -3 0:00 :00 Room 6 SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD :00 5:00 h. :00 3:30 Auditorium A Track: Multidisciplinary Intervention in Dual Symposium SY30 MULTIMODAL APPROACHES FOR ADHD AND DUAL DISORDERS Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM. Valencia, España. NON-PHARMACOLOGICAL INTERVENTIONS IN CHILDREN AND ADOLESCENTS WITH ADHD Maite Ferrin, The Huntercombe Hospital Maidenhead, Institute of Psychiatry London. London, www.cipd05.com Pág. 7
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 United Kingdom. THE EFFICACY AND LIMITATIONS OF PHARMACOLOGICAL MANAGEMENT OF ADULT ADHD AND DUAL DISORDERS Eugenio H. Grevet, Federal University of Rio Grande Do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil. THE EXPANDING ROLE OF NUTRITIONAL PSYCHIATRY AND LIFESTYLE MEDICINE FOR BIPOLAR DISORDERS Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM. Valencia, España. INTEGRATED BIOPSYCHOSOCIAL-SPIRITUAL TREATMENT FOR ADDICTIONS AND CO- OCCURRING DISORDERS Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA. :00 :45 Room Track: Multidisciplinary Intervention in Dual :45 3:30 Room Track: Personality :00 4:00 Room -3 :00 3:30 Room 4 Track: Cannabis and Dual Main Lecture - ML08 DUAL DISORDERS AND MENTAL DISORDERS Carmen Leal, Facultad De Medicina De Valencia. Comunitat Valenciana, España. Speaker: Julio Sanjuan, Universitat de Valencia. Comunitat Valenciana, España. Main Lecture - ML09 UPDATE: PSYCHOPATHY IN DUAL PATHOLOGY Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d Hebron. Barcelona, España. Speaker: Rafael Torrubia, Universidad Autónoma de Barcelona. Barcelona, España. Debate Forum DF0 WPA SECTION ON DUAL DISORDERS By invitation only Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine University of Miami. FL, USA. Co-chairs: Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Nady El-Guebaly, University of Calgary. Alberta, Canada. Symposium SY3 RESEARCH IN NEUROBIOLOGY AND CLINICAL TRIALS REGARDING DISORDERS DUE TO CANNABIS ABUSE AND IN PSYCHOEDUCATIONAL GROUP THERAPY FOR PATIENT S FAMILIES www.cipd05.com Pág. 8
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Josep Solé, Centre D'Atenció I Seguiment De Drogodependències Benito Menni. Barcelona, España. NEUROPSYCHOLOGICAL DISORDERS ASSOCIATED WITH CANNABIS USE Laura Blanco, Centre D'Atenció I Seguiment De Drogodependències Benito Menni. Barcelona, España. DATA FROM CLINICAL RESEARCH CANNABIS ADDICTION Begoña Gonzalvo, Centre D'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España. PSYCHOEDUCATIONAL GROUP THERAPY AIMED AT FAMILY MEMBERS OF PEOPLE WITH SUBSTANCE DEPENDENCE DISORDER LINKED TO A DRUG ADDICTION CENTER Alfredo Felices de la Fuente, Centre D'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España. :00 3:30 Room 5 Track: Multidisciplinary Intervention in Dual Symposium - SY3 NEW PSYCHOACTIVE DRUGS: APPROACH, PERSPECTIVES AND PSYCHOPATHOLOGY Helen Dolengevich, Hospital Universitario Del Henares. Madrid, España. MEDICAL APPROACH TO THE INTOXICATED PATIENT. WHAT NEEDS TO CHANGE? Daniel Sánchez, Hospital Universitario La Fe. Valencia, España. NEWEST PSYCHOACTIVE DRUGS ON THE NET Jorge Gómez-Arnau, Hospital Universitario Del Henares. Madrid, España. SYNTHETIC CANNABINOIDS AND PSYCHOPATHOLOGY: PSYCHOSIS IN THE SPOTLIGHT Carlos Parro, C.S. Mental Retiro. Hospital Universitario Gregorio Marañón. Madrid, España. :00 3:30 Room 6 Track: Epidemiology and Dual Invited Symposium IS09 EPIDEMIOLOGY Josep Mª Haro, Hospital San Joan de Deu. Barcelona, España. EPIDEMIOLOGY OF ALCOHOL CONSUMPTION IN DUAL PATIENTS Teresa Brugal, Agencia de Salut Pública Barcelona. Barcelona, España. GENDER DIFFERENCES IN PACIENTS WITH DUAL ALCOHOLISM Jesús Perez Pazos, Centre d'atenció I Seguiment de Drogodependències Vall d'hebron. Barcelona, España. ALCOHOL CONSUMPTION IN ADOLESCENTS IN DUAL PATHOLOGY Rodrigo Córdoba, Centro de Investigaciones del Sistema Nervioso (Grupo Cisne). Bogotá, Colombia. :00 3:30 Room 7 Track: Child & Adolescent Psychiatry Symposium - SY33 ATTENTION TO ADOLESCENTS AND YOUNG ADULTS IN THE INSTITUTE OF ADDICTIONS MADRID SALUD. CHALLENGE IN THE INTERVENTION OF DUAL PATHOLOGY www.cipd05.com Pág. 9
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Antonio Prieto, Madrid Salud (Salud Pública del Ayuntamiento de Madrid), España. DOES THE PROCESS MANAGEMENT INCREASE THE QUALITY AND EFFICIENCY IN THE CARE OF ADOLESCENTS WITH PROBLEMS OF ADDICTION? Mª Teresa Pérez, Instituto de Adicciones de Madrid. Madrid, España. INTERVENTION WITH ADOLESCENTS WITH DUAL DIAGNOSIS FROM A DEPENDENCE ADDICTION CENTER Marina Delgado, Instituto de Adicciones de Madrid. Madrid, España. TREATMENT OF ADOLESCENTS AND YOUNG ADULTS IN A SPECIFIC THERAPEUTIC RESOURCE Pedro Pablo Herraiz, Instituto de Adicciones de Madrid. Madrid, España. :00 3:30 Room 8 Track: Psychosis :00 3:30 Room 9 :00 3:30 Room 0 Track: Planning, regulations and resource management Symposium - SY34 PSYCHOSIS AND PSYCHOACTIVE SUBSTANCES: AN EVER CHANGING SCENARIO Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy. COCAINE INDUCED PSYCHOTIC DISORDERS AND PSYCHOTIC SYMPTOMS IN COCAINE DEPENDENT PATIENTS Carlos Roncero, Universidad Autónoma de Barcelona, España. THE LYSERGIC PSYCHOMA Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy. PSYCHOTIC EXPERIENCES AND SUBSTANCE ABUSE: THE CLUB SCENE IN IBIZA Cristina Merino del Villar, Hospital Can Misses. Ibiza, España. SYNTHETIC CANNABINOIDS AND "SPICEOPHRENIA" Rita Santacroce, University "G.D'Annunzio", Chieti, Italy. Duccio Papanti, University of Trieste, Trieste, Italy. Medical Educational Room Sponsored by the Foundation on Dual Symposium - SY35 DEVELOPMENT OF A NOVEL IN-PATIENT SERVICE MODEL AND PROGRAM FOR DUAL DISORDERS Bridin Murnion, Sydney Local Health District. Sydney, Australia. DEVELOPING A MODEL OF CARE FOR COMPLEX CO-MORBIDITY-A SYSTEMS PERSPECTIVE Bridin Murnion, Sydney Local Health District. Sydney, Australia. STAGE 3 CLIENTS PROGRAM Danielle Florida, Concord Hospital. Concord, NSW, Australia. STAGE CLIENTS PROGRAM Lisa Juckes, Concord Hospital. Concord, NSW, Australia. DEVELOPING A MODEL OF CARE FOR COMPLEX CO-MORBIDITY-THE PATIENT AND STAFF PERSPECTIVE www.cipd05.com Pág. 30
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Wendy Kerley, Concord Hospital. Concord, NSW, Australia. :00 :45 Room Track: Evaluation processes in Dual :45 3:30 Room Track: Psychotherapeutic Treatment in Dual :00 3:30 Room Workshop - WS08 ADOLESCENT TO PARENT VIOLENCE IN ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL DISORDERS: A COMPARATIVE DIAGNOSTIC STUDY Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. DIAGNOSTIC CRITERIA FOR ADOLESCENT TO PARENT VIOLENCE IN ADOPTED AND NON- ADOPTED TEENAGERS AND YOUNG ADULT PATIENTS Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH CHILD TO PARENT VIOLENT BEHAVIOUR M. Àngels Feliu, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. Workshop WS09 MINDFULNESS FOR TREATING DUAL DISORDERS Rosa Tejedor, Centro de Atención Drogodependencias. Fundacion Althaia. Xarxa Assitencial Universitaria de Manresa. Barcelona, España. MINDFULNESS FOR TREATMENT TO SUBSTANCE USE DISORDERS Rosa Tejedor, Centro de Atención Drogodependencias. Fundacion Althaia. Xarxa Assitencial Universitaria de Manresa. Barcelona, España. MINDFULNESS IN RELAPSE PREVENTION Antonia Raich, Althaia Xarxa Assistencial Universitaria Manresa. Barcelona, España. Oral Communications - OC06 Chairs: Enriqueta Ochoa, Hospital Ramón y Cajal de Madrid, España. Luis Patricio, Casa de Saude de Carnaixade. Carnaixade, Portugal. TRANSLATING EXPERIMENTAL FINDINGS INTO THE CLINICAL CONSULTING ROOM: A CASE EXAMPLE Cynthia Cabral City College of New York, City University of New York, NY, USA. St. John s University, Queens, USA. CANNABINOID HYPEREMESIS SYNDROM. A REPORT OF SIX NEW CASES AND A RESUME OF PREVIOUS REPORTS C. Contreras Narváez¹, M. Mola Gilbert², E. Batlle de Santiago², E. Giné Serven¹, J. Bigas Farreres³ www.cipd05.com Pág. 3
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Departamento de Salud Mental. Hospital de Mataró. Barcelona, España. Centro de atención a las drogodependencias. Hospital de Mataró. Barcelona, España. 3 Servicio de Urgencias. Hospital de Mataró. Barcelona, España. CHANGES IN BODY WEIGHT AMONG BIPOLAR PATIENTS PARTICIPATING IN A RANDOMIZED, PLACEBO-CONTROLLED TRIAL (RCT) OF VARENICLINE FOR SMOKING CESSATION De Matteis M., Clinebell K, Rai A 3 ; Chengappa KNR Hospital General Universitario Gregorio Marañon, Madrid, España. UPMC, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA. 3 St. Mary's Mercy hospital, Livonia, MI, USA. EFFECTS ON BRAIN FUNCTION OF USE OF MARIJUANA IN SCHOOLBOYS EVIDENCED BY NEUROPSYCHOLOGICAL TESTING SHOWN BY NEURO-SPECT IMAGES Ismael Mena, Anneliese Dörr, Sandra Viani, Sonia Neubauer, María Elena Gorostegui, María Paz Dörr, Diana Ulloa 3 Facultad de Medicina, Universidad de Chile, Chile. Clínica Las Condes, Santiago, Chile. 3 Facultad de Ciencias Sociales, Universidad de Chile, Chile. MARIJUANA TEEN CONSUMERS: IMPLICATIONS FOR FAMILY AND SCHOOL Anneliese Dörr, M. Elena Gorostegui, Sandra Viani, M. Paz Dörr B. Universidad de Chile, Facultad de Medicina, Santiago de Chile, Chile. Universidad Católica de Chile, Facultad de Psicología, Santiago de Chile, Chile. 3 Hospital Clínico, Universidad Católica de Chile, Santiago de Chile, Chile. PALIPERIDONE PALMITATE. AN EXPERIENCE IN DUAL PATHOLOGY R. Salmons Aleu, T. Borràs Cabacés Hospital Universitario S. Joan, Reus, Tarragona, España. FAMILIAL FACTORS ASSOCIATED WITH DEVELOPMENT OF ALCOHOL AND MENTAL HEALTH COMORBIDITY C.L. Salom, G.M. Williams, J.M. Najman, R. Alati University of Queensland, Brisbane, Australia. SEX DIFFERENCES IN THE EFFECTS OF IMMUNE ACTIVATION DURING THE GESTATIONAL STAGE ON COCAINE SELF-ADMINISTRATION IN ADULTHOOD: PRELIMINARY DATA FROM A MODEL OF DUAL DIAGNOSIS R. Santos-Toscano, D. Roura-Martínez, M. Ucha-Tortuero, MA. Assís, M. Miguéns, E. Ambrosio, A. Higuera-Matas UNED. Madrid, España. APPROACH TO DUAL PATHOLOGY IN THE PSYCHIATRIC HOSPITAL Juan Rosales Mexican Academy of Dual Pathology, Mexico. www.cipd05.com Pág. 3
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 3:30 5:00 Auditorium A Track: Attention Deficit 3:30 5:00 Room Track: Psychosis 3:30 5:00 Room 4 Track: Cannabis and Dual Invited Symposium - IS0 ADHD AS A CAUSAL FACTOR IN DUAL DISORDERS Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. GENETIC RISK FOR ADD IN ADDICTED PATIENTS Josep A. Ramos Quiroga, Hospital Universitari Vall d'hebron. Barcelona, España. INFLUENCE OF ADHD IN ADDICTION EVOLUTION Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. NEED OF TREATMENT IN DUAL ADHD José Martínez-Raga, Unidad de Conductas Adictivas de Gandia, CEU Cardenal Herrera. Valencia, España. Invited Symposium - IS SHARED VULNERABILITY TO DUAL DISORDERS, PSYCHOSIS AND CANNABIS ADDICTIONS Julio Vallejo, Universidad de Barcelona, España. CANNABIS IN FIRST EPISODE PSYCHOTIC PATIENTS Miquel Bernardo, Hospital Clínico. Universitat de Barcelona, España. NEUROIMAGING IN DUAL DISORDER PATIENTS CONSUMERS OF CANNABIS Benedicto Crespo- Facorro, Hospital Universitario Marqués de Valdecilla. Santander, España. FOLLOW UP, CANNABIS IN-TAKE AND THE PSYCHOSIS EVOLUTION Ana González Pinto, Hospital Santiago Apóstol. Vitoria, España. Symposium SY36 THINGS TO KNOW OF CANNABIS CONSUMPTION IN DUAL PATIENTS Mercedes Balcells, Hospital Clínic I Universitari De Barcelona. Barcelona, España. INSTRUMENTS FOR ASSESSING CANNABIS USE IN PSYCHIATRIC PATIENTS Hugo López-Pelayo, Grup de Recerca En Addicions Clínic. Hospital Clínic i Universitari de Barcelona. Barcelona, España. COGNITIVE IMPAIRMENT IN CANNABIS USERS: FROM RESEARCH TO CLINICAL PRACTICE Albert Batalla-Cases, Tactus Addiction Treatment. Deventer, The Netherlands. CANNABINOID HYPEREMESIS SYNDROME: EPIDEMIOLOGY, ASSESSMENT AND DIFFERENTIAL DIAGNOSIS Laia Miquel, Grup de Recerca en Addicions Clínic. Hospital Clínic i Universitari de Barcelona. Barcelona, España. PSYCHOACTIVE COMPONENTS OF CANNABIS AND THEIR CLINICAL IMPLICATIONS Cristina Casajuana, Grup De Recerca En Addicions Clínic. Hospital Clínic i Universitari de Barcelona. Barcelona, España. www.cipd05.com Pág. 33
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 3:30 5:00 Room 5 Track: Eating 3:30 5:00 Room 6 Track: Planning, regulations and resource management 3:30 5:00 Room 7 Track: Sick Doctors and Dual Invited Symposium IS FOOD AND DRUGS: BINGE-EATING DISORDERS Ignacio Basurte, Hospital General Universitario Gregorio Marañón. Madrid, España. IS EATING DISORDER AN ADDICTIVE DISORDER? Luis Rojo Moreno, Hospital Universitario y Politécnico La Fe. Valencia, España. Luis Rojo Bofill, Servicio de Psiquiatría. HU La Fe, Valencia, España. IS BINGE EATING DISORDER AN EVOLUTION OF THE ADDICTION? Francisco J. Vaz, Complejo Hospitalario Universitario UNEX. Badajoz, España. SYMPTOMS OF ADHD IN ED AS A RISK FACTOR FOR DD Marina Díaz Marsá, Hospital Clínico San Carlos. Madrid, España. Symposium SY37 CARE PATTERNS IN DUAL PATHOLOGY. NEARING ITS EFECTIVENESS AND EFFICIENCY THROUGH THE FOLLOW UP OF PATIENTS? Indalecio Carrera, Asociación Ciudadana de Lucha contra la Droga (ACLAD). A Coruña, España. SPECIFIC INTERVENTIONS IN THE UPD OF COIMBRA Carla Torres, Unidade de Patologia Dual, Centro Hospitalar Universitário de Coimbra, Portugal. DUAL PATHOLOGY IN ADDICTION NETWORKS OF HEALTH AREAS IN PORTO AND CORUÑA José A. Santos, Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências (SICAD), Portugal. THE DUAL PATHOLOGY IN MENTAL HEALTH NETWORK IN LA CORUÑA Mª Carmen García, Complejo Hospitalario Universitario de A Coruña, Universidad de Santiago de Compostela. Galicia, España. ANALYSIS OF CARE MODELS AND PROPOSALS FOR IMPROVING THEIR QUALITY Indalecio Carrera, Asociación Ciudadana de Lucha contra la Droga (ACLAD). A Coruña, España. Symposium - SY38 CARE PROGRAM FOR SICK PHYSICIANS: HEALTH AND QUALITY INTERVENTION Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Castilla la Mancha, España. PAIME REPORT. FUTURE WORK LINES Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Castilla la Mancha, España. THE PSYCHOLOGIST ROLE IN PAIME. INTERVENTION STRATEGIES BASED ON MEDICAL ASSOCIATIONS Isabel Montoya, Psicologa Clinica del PAIME de Ciudad Real. Castilla la Mancha, España. www.cipd05.com Pág. 34
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 PATIENT PAIME: DESIGN SOCIAL PROTECTION Nina Mielgo, Fundación Protección Social Médicos Príncipe de Asturias. Oviedo, España. 3:30 5:00 Room 8 Track: Behavioral addictions / Gambling 3:30 5:00 Room 9 3:30 5:00 Room 0 Track: Planning, regulations and resource management 3:30 4:5 Room Track: Cannabis and Dual Symposium SY39 GAMBLING DISORDERS AND PSYCHOTIC DUAL DISORDERS (SCHIZOPHRENIA) Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia, España. PSYCHIATRIC COMORBIDITY ASSOCIATED WITH PATHOLOGICAL GAMBLING Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia, España. CLINICAL AND PSYCHIATRIC IMPLICATIONS OF PATHOLOGICAL GAMBLING IN SCHIZOPHRENIA Gemma Parramon, Hospital Universitari Vall d'hebron. Barcelona, España. PSYCHOLOGICAL IMPLICATIONS OF SCHIZOPHRENIA IN PATHOLOGICAL GAMBLING. Montserrat Gómez, Asociación Barcelonesa de Ludopatía y Adicciones/ Instituto de Diagnostico Psicológico, Barcelona, España. Medical Educational Room Sponsored by the Foundation on Dual Symposium SY40 TREATMENT SYSTEMS/SERVICES FOR DUAL DISORDERS: EXPERIENCES IN DIFFERENT COUNTRIES Christian G. Schütz, University of British Columbia. Vancouver, Canada. Co-chair: Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España. THE TREATMENT OF DUAL DISORDER PATIENTS IN SWITZERLAND Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàctel, Switzerland. THE RESTRUCTURING OF DUAL DIAGNOSES HEALTH CARE IN THE BRITISH COLUMBIA, CANADA: IS THE PATH THE GOAL? Christian G. Schütz, University of British Columbia. Vancouver, Canada. CONTRASTING DUAL DIAGNOSES APPROACHES IN AUSTRALIA TO APPROACHES IN OTHER CONTINENTS Enrico Cementon, University of Melbourne. Melbourne VIC, Australia. Workshop - WS0 DUAL DISORDERS AND LIBERALISM Chair/ Speaker: Susana E. Méndez, Enterhealth, Residential and Outpatient Services, Dallas TX, USA. www.cipd05.com Pág. 35
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 4:5 5:00 Room Track: Psychotherapeutic Treatment in Dual 3:30 5:00 Room Workshop - WS COGNITIVE-AFFECTIVE MECHANISMS INVOLVED IN THE INTERPRETATION OF DRUG USE IN DUAL DISORDERS Humberto Guajardo, Universidad de Santiago de Chile. Santiago de Chile, Chile. POSRACIONALISTIC PERSPECTIVE IN DUAL PATHOLOGY Humberto Guajardo, Universidad de Santiago de Chile. Santiago de Chile, Chile. INTERPRETATED EFFECT ON DRUG ABUSE Diana Kushner, Universidad de Santiago de Chile. Santiago de Chile, Chile. Oral Communications OC07 Chairs: Carolina Franco, Centre d Higiene Mental Les Corts. Barcelona, España. Enrique Mendoza, Asociación Psiquiátrica de América Latina (APAL), Guatemala. HIGHER FREQUENCY OF C.3435 OF THE ABCB GENE IN PATIENTS WITH TRAMADOL DEPENDENCE DISORDER Dalia Enaba, Heba El Baz, Hamdy Moselhy Psychiatry Department and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Medicine, UAE University, Al Ain, United Arab Emirates. THE BINOMIAL VIOLENCE AND ALCOHOL P.M. Fuertes Psychology. Astorga. León, España. ENERGY DRINKS: AN EMERGING HEALTH PROBLEM Sara Meca Zapatero Centro G. SINadicciones, (Gabinete Psicológico especializado en la Prevención y Rehabilitación de Conductas Adictivas, Psicología Clínica y Patología Dual) Valencia, España. DETOXIFICATION WITH METHADONE FOR THE TREATMENT OF PRESCRIPTION OPIOID USE DISORDER: TWO CLINICAL CASES Oriolo G, Barrio P, Balcells M, Institut Clínic of Neuroscience (ICN). Hospital Clínic de Barcelona, Catalonia, España. Institut d Investigacions Biomédiques August Pi i Sunyer (IDIBAPS). España. BACLOFEN : MAINTENANCE OF ABSTINENCE IN ALCOHOL DEPENDENT PATIENTS ATTENDING LIVER CLINIC Lynn Owens, Abi Rose, Andrew Thompson, Ian Gilmore, Munir Pirmohamed, Paul Richardson Royal Liverpool Hospital Trust. United Kingdom. University of Liverpool. United Kingdom. www.cipd05.com Pág. 36
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 DUAL PATHOLOGY ON ALCOHOLIC PEOPLE: A DESCRIPTIVE STUDY M.A. García Carretero, M. Robles Martínez, M.A. Jordán Quintero 3, J. Gibert Rahola 4 CTS39 Grupo Multidisciplinar para el progreso de la Salud Mental, Universidad de Cádiz, España. CTA ARCA y Hospital Universitario Puerta del Mar, Cádiz, España. 3 Hospital Universitario Puerta del Mar, Cádiz, España. 4 CTA ARCA y Departamento Neurociencias, Universidad de Cádiz, España. INJECTION AND NON INJECTION DRUG USERS PRESENTING IN A TEACHING HOSPITAL IN SOKOTO, NIGERIA. A REPORT OF SOCIOCULTURAL FACTOR AS BARRIER IN MANAGEMENT M.A. Yunusa,, A. Obembe, Usman Danfodiyo University, Sokoto, Nigeria. Usman Danfodiyo University Teaching Hospital, Sokoto, Nigeria. DIFFERENCES BETWEEN OPIATE AND NON-OPIATE USING POPULATIONS: CHARACTERISTICS, MOTIVATION, RETENTION AND OUTCOMES IN DUAL DIAGNOSIS TREATMENT Siobhan A. Morse Foundations Recovery Network in Nashville, Tennessee, USA. THE ASSOCIATION BETWEEN GRIT AND DUAL DIAGNOSIS AMONG INPATIENTS WITH ALCOHOL USE DISORDERS M.L. Griffin, ; R.D. Weiss. Harvard Medical School, Boston, Massachusetts, USA. Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts, USA. 5:00 6:30 h. 5:00 5:45 Auditorium A Track: Basic Research 5:45 6:30 Auditorium A Track: Attention Deficit Main Lecture ML0 ADHD AND ADDICTIONS, A PATTERN OF DUAL DISORDERS Francisco de Asís Babín, Plan Nacional Sobre Drogas, España. Speaker: Nora Volkow, National Institute on Drug Abuse (NIDA), Bethesda. MD, USA. Main Lecture ML NEW PHARMACOLOGICAL APPROACHES IN ADHD AND DUAL DISORDERS Carlos Mur, Hospital Psiquiátrico José Germain, Leganés, España. Speaker: Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. 5:00 6:30 Invited Symposium - IS3 www.cipd05.com Pág. 37
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Room Track: Behavioral Addictions / Gambling 5:00 6:30 Room -3 Track: Psychotherapeutic Treatment in Dual 5:00 6:30 Room 4 Track: Cannabis and Dual 5:00 6:30 Room 5 Track: Multidisciplinary Intervention in Dual THE HOUSE IS ON FIRE: GAMBLING DISORDERS AND DUAL PATHOLOGY Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. INTERNET USE AND DUAL DISORDER Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France. GAMBLING RISKS AND DUAL DISORDERS Nady El-Guebaly, University of Calgary. Alberta, Canada. ADDICTION TO SMART PHONE Mariano Choliz, Universidad de Valencia, España. Symposium SY4 RIOD: EMERGING NEEDS IN DUAL PATHOLOGY IN DEVELOPING IBEROAMERICAN COUNTRIES Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Co-chair: Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Castilla la Mancha, España. PRESENTATION OF RIOD (RED IBEROAMERICANA DE DROGODEPENDENCIAS) Felisa Pérez, Red Iberoamericana de Drogodependencias, Madrid, España. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Symposium SY4 CANNABIS, CANNABINOIDS AND DUAL PSYCHIATRIC DISORDERS Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel. A LONGITUDINAL EXPLORATION OF THE IMPACT OF CANNABIS USE ON INCIDENCE AND COURSE OF ILLNESS OF MOOD DISORDERS Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel. CLINICAL CHARACTERISTICS OF HOSPITALIZED SYNTHETIC CANNABINOID USERS Gal Shoval, Geha Mental Health Center, Tel Aviv University. Tel Aviv, Israel. CANNABIS USE AND HALLUCINOGEN PERSISTING PERCEPTION DISORDER: A CASE SERIES Arturo Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. Symposium SY43 DRUG USE HAS NO AGE LIMIT. DUAL PSYCHOPATHOLOGY AND INTEGRATED TREATMENT APPROACH IN OLD-AGE Antonio Bulbena, Parc de Salut Mar, Universitat Autònoma de Barcelona. Barcelona, España. PSYCHOPATHOLOGY IN GERIATRICS www.cipd05.com Pág. 38
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Manuel Sánchez, Unidad de Psiquiatría Geriátrica, Hospital Sagrat Cor Martorell. Barcelona, España. INTEGRATED APPROACH TO THE ELDERLY PATIENT Ángel Moríñigo, Psiquiatra Ejercicio Privado. Sevilla, España. DRUG USE HAS NO AGE LIMIT Elena Ros-Cucurull, Hospital Universitari Vall d Hebron. Barcelona, España. 5:00 6:30 Room 6 Track: Alcohol 5:00 6:30 Room 7 Track: Psychopharmacological Treatments in Dual Symposium SY44 CLINICAL IMPLICATIONS OF DRUG CONSUMPTION: INFLUENCE OF DUAL PATHOLOGY Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland. ASSESSMENT OF PSYCHIATRIC COMORBIDITIES IN AN OPIATE INTEGRATED TREATMENT IN HO CHI MINH, VIETNAM Jean-Pierre Daulouede, Centre Hospitalier de la CA'te Basque, Bayonne, France. RELATIONSHIP BETWEEN CANNABIS AND PSYCHOSIS: A DANGEROUS LINK? Logos Curtis, Unité de psychiatrie du jeune adulte (JADE), Service de Psychiatrie Générale, Département de Santé mentale, Hôpitaux Universitaires de Genève, Switzerland. BRIEF INTERVENTIONS IN ALCOHOLISM; ARE THEY USEFUL IN DUAL PATIENTS? Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland. Symposium SY45 CLOZAPINE FOR SCHIZOPHRENIA AND CO-OCCURRING SUBSTANCE USE: WORTH A SECOND LOOK? Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. CLOZAPINE FOR SUBSTANCE USE DISORDERS IN SCHIZOPHRENIA: CURRENT KNOWLEDGE AND A UNIFYING HYPOTHESIS Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. WHAT IS UNUSUAL ABOUT CLOZAPINE? Torgny Svensson, Karolinska Institute. Solna, Sweden. COMPARING THE EFFECT OF CLOZAPINE AND RISPERIDONE ON CANNABIS REWARD IN PATIENTS WITH SCHIZOPHRENIA AND CANNABIS USE DISORDER: A RANDOMIZED FMRI STUDY Marise Machielsen, Academic Psychiatric Center. Amsterdam, The Netherlands. TOWARD A VALID ANIMAL MODEL OF ALCOHOL USE DISORDER IN SCHIZOPHRENIA: CLOZAPINE REDUCES ALCOHOL DRINKING IN THE NEONATAL VENTRAL HIPPOCAMPAL LESIONED RAT Jibran Khokhar, Geisel School of Medicine at Dartmouth. Hanover NH, USA. www.cipd05.com Pág. 39
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 5:00 6:30 Room 8 Track: Post-Traumatic Stress 5:00 6:30 Room 9 5:00 6:30 Room 0 Track: Epidemiology and Dual 5:00 5:45 Room Track: Suicide & Dual Symposium SY46 TRAUMA CARE FOR THE MOST VULNERABLE Michael Krausz, University of British Columbia. Vancouver, Canada. ADDICTION, TRAUMA, MENTAL ILLNESS - TREATMENT OPTIONS FOR COMPLEX CONCURRENT DISORDERS Michael Krausz, University of British Columbia. Vancouver, Canada. GENDER IDENTITY DISORDER & SUD: LET'S GO DEEP INTO THE ABYSS OF TRAUMA Ester di Giacomo, Department of Translational Medicine and Surgery-University of Milano, Italy. TRAUMA EXPERIENCES, AFFECTIVE INESTABILITY, BIPOLAR DISORDER AND ASSOCIATED SUBSTANCE USE: UN-DERLYING MECHANISM AND THERAPEUTIC CONSEQUENCES Christian G. Schütz, University of British Columbia. Vancouver, Canada. Medical Educational Room Sponsored by the Foundation on Dual Symposium - SY47 IDENTIFYING PSYCHIATRIC PATIENTS VULNERABLE TO SUBSTANCE MISUSE Manuel Gurpegui, Universidad de Granada, España. AN OVERVIEW OF THE OVERLAP BETWEEN PSYCHIATRIC DISORDERS AND VARIETIES OF SUBSTANCE MISUSE José M. Martínez-Ortega, Instituto de Neurociencias, Universidad de Granada. Granada, España. WHO ARE THE PATIENTS WITH DEPRESSION MORE LIKELY TO ABUSE ALCOHOL? Conor K. Farren, Trinity College Dublin, St Patrick's University Hospital. Dublin, Ireland. HOW DO PATIENTS WITH BIPOLAR DISORDER OR SCHIZOPHRENIA DIFFERENTIALLY REACT TO OPIATES OR STIMULANTS? Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. ARE PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER ADDICTED TO TOBACCO A DIFFERENT SUBPOPULATION WITHIN THEIR DIAGNOSTIC GROUP? Manuel Gurpegui, Universidad de Granada, España. Workshop - WS VIOLENCE AND SELF-VIOLENCE IN DUAL DISORDERS SELF-VIOLENCE IN DUAL DISORDERS Mª Dolores Braquehais, Hospital Universitari Vall d'hebron. Universitat Autònoma de Barcelona. CIBERSAM. Barcelona, España. NEUROBIOLOGY OF SUICIDAL BEHAVIOR IN ADOLESCENTS WITH DUAL DISORDERS www.cipd05.com Pág. 40
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Mª Dolores Picouto, Sant Joan de Déu University Hospital, Universitat de Barcelona. Barcelona, España. 5:45 6:30 Room Track: Psychopharmacological Treatments in Dual 5:00 6:30 Room Workshop - WS3 GUIDELINES FOR THE PHARMACOLOGICAL AND PSYCHOLOGICAL TREATMENT OF ADULT PATIENTS WITH A PSYCHIATRIC DISORDER AND A COMORBID SUBSTANCE USE Miquel Bernardo, Hospital Clínico. Universitat de Barcelona. Barcelona, España. Speaker: DEVELOPMENT OF THE CLINICAL GUIDELINE OF DUAL PATHOLOGY: GROUP COMPOSITION, MEETINGS, PICO QUESTIONS, ASSESSMENT OF THE SCIENTIFIC EVIDENCE USING THE GRADE SYSTEM, AND RECOMMENDATIONS Luis San, Sant Joan de Deu. Barcelona, España. Oral Communications - OC08 Chairs: Arkaitz Aguerretxe, Cabinet en Libéral, BIZIA/SETHS, CSAPA BIZIA/Medecins du Monde, France. Elvia Velásquez, Alad (Latinoamerican Association on Addiction). Colombia. PERSONALITY DISORDER AND ADDICTION S. Božović, J.Đorđević, S. Čelebić, D. Pavlović 3, M. Prvulović. Special Hospital for Substance Abuse, Belgrade, Serbia.. Hospital for Psychiatric Diseases Dr L Lazarević, Belgrade, Serbia. 3. Faculty of special education and rehabilitation, Belgrade, Serbia ADOLESCENT SMOKING AND SYMPTOMS OF DEPRESSION/ANXIETY: EVIDENCE FOR A SELF- MEDICATION HYPOTHESIS N. Carceller-Maicas, A. Martinez-Hernaez, Susan DiGiacomo, Universitat Rovira i Virgili. Tarragona, España. University of Massachusetts at Amherst, USA. RESEARCH OF THE COMORBIDITY BETWEEN BORDERLINE PERSONALITY DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDER IN AN ADULT PATIENTS SAMPLE C. Maruottolo,, A. González, O. Landeta Rodríguez,4, J. Balerdi 3, M. Fernández 3, A. Hernández 3 AMSA-Teaching and Research Unit, Bilbao, Bizkaia, España. Medicine Faculty, Universidad País Vasco, Bizkaia, España. 3 AMSA Unidad de Día, Bilbao, Bizkaia, España. 4 UNED-Bizkaia, Bizkaia, España. STUDY OF THE EFFECTIVENESS OF A PSYCHODYNAMIC AND SOCIODYNAMIC TREATMENT IN PATIENTS WITH DUAL PATHOLOGY C. Maruottolo Sardella,, O. Landeta Rodríguez,3, C. LLorrens Herrera 4 www.cipd05.com Pág. 4
Sunday April 9 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 AMSA-Teaching and Research Unit, Bilbao, Bizkaia, España. Medicine Faculty, Universidad País Vasco, Bizkaia, España. 3 AMSA Unidad de Día, Bilbao, Bizkaia, España. 4 UNED-Bizkaia, Bizkaia, España. THE RELATIONSHIP BETWEEN VULNERABLE ATTACHEMENT STYLE, PSYCHOPATHOLOGY, DRUG ABUSE, AND RETENTION IN TREATMENT AMONG METHADONE MAINTENANCE TREATMENT PATIENTS D. Potik,, E. Peles,3, Y. Abramsohn, M. Adelson, S. Schreiber,3 Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and Research, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. Department of Psychiatry, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. 3 Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel. TREATMENT OUTCOMES IN A DUAL DIAGNOSIS THERAPEUTIC COMMUNITY: A FOLLOW-UP STUDY Virginio Salvi, Fabrizio Boccardo, Patrizia Giannini, Metello Corulli Comunità Terapeutica Il Porto ONLUS, Moncalieri (TO), Italy. 6:30-7:30 h. SELF HARM AMONG WOMAN INJECTING DRUG USERS (IDUS) FROM NORTH EASTERN INDIA Kimneihat Vaiphei St.Johns Medical College and Hospital, India. 6:30 7:5 Auditorium A Track: Bipolar 7:5 7:30 Auditorium A Plenary Session - PS03 ON THE BLINK: BIPOLAR AND DUAL DISORDERS Enrique Álvarez, Hospital San Pau de Barcelona, España. Speaker: Eduard Vieta, Hospital Clínic de Barcelona. Universitat de Barcelona. España. SESSION AWARD FOR BEST POSTER WINNER www.cipd05.com Pág. 4
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 h. 08:30 0:00 Room Track: Multidisciplinary Intervention in Dual 08:30 0:00 Room 3 Track: Tobacco Symposium SY48 RESOURCE OPTIMIZATION FOR PATIENTS WITH DRUG ADDICTION DUAL DISORDERS Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Castilla la Mancha, España. HOSPITAL COORDINATION: ANOTHER WAY OF DUAL PATIENTS TO UCA ACCESS Gloria Cordeiro-Crespo, Servicio de Psiquiatría Mancha Centro de Alcázar de San Juan. Ciudad Real, España. FLOOR SUPPORT THERAPY IN DUAL PATHOLOGY PATIENTS Paloma Sánchez, Unidad de Conductas Adictivas. Ciudad Real, España. IMPROVING ADHERENCE OF DUAL PATIENTS : FROM THE STREET WORKER TO THE UCA Mª Luisa Celorrio, Complejo Hospitalario Universitario de Albacete. Albacete, España. Symposium SY49 TOBACCO AND DUAL PATHOLOGY: TOOLS FOR ACTION César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. SMOKING IN PSYCHIATRIC PATIENTS: NEGLECTED EPIDEMIC Débora Serebrisky, Centro de Investigaciones Clínicas WM. Argentina. DUAL ADDICTION: NICOTINE AND COCAINE DEPENDENCE Iván Montoya, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, USA. SMOKING AND PATHOLOGICAL GAMBLING César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. SMOKING AND MENTAL HEALTH PROFESSIONALS IN ARGENTINA Fernando Müller, Proyecto MEDEF, Centro de Investigaciones Clínicas WM, APSA, EGAMA, Unión Antitabáquica Argentina, Argentina. 08:30 0:00 Room 4 Track: Training in Dual Diagnosis New Forum - NF0 STATE OF DUAL DISORDER TRAINING, CLINICAL SERVICES AND RESEARCH ACROSS COUNTRIES Yatan Pal Singh, All India Institute of Medical Sciences (AIIMS) New Delhi, India. STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN FRANCE www.cipd05.com Pág. 43
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Amine Benyamina, Centre D'Enseignement, de Recherche Et de Traitement des Addictions. Paris, France. THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN ISRAEL Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel. THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN SPAIN José Martínez-Raga, Hospital Universitario Doctor Peset y Universitat de Valencia, España. THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN INDIA Yatan Pal Singh, All India Institute of Medical Sciences (AIIMS) New Delhi, India. 08:30 0:00 Room 5 Track: Sleep and Dual Diagnosis 08:30 0:00 Room 6 Track: Penitentiary (Prisons) and Dual 08:30 0:00 Room 7 Track: Multidisciplinary Intervention in Dual Symposium SY50 AM I AWAKE OR ASLEEP? SLEEP DISORDERS IN DUAL PATHOLOGY Carmen Barral, Hospital Universitari Vall d'hebron. Barcelona, España. NEUROPHYSIOLOGY OF SLEEP AND ITS DISORDER ADDICTION Fermín Ordoño, Hospital Arnau de Vilanova. Lleida, España. RELATIONS BETWEEN SLEEP AND ADDICTIONS Francesca Cañellas, Hospital Son Dureta. Palma de Mallorca, España. TREATMENT OF SLEEP DISORDERS IN DUAL PATIENTS Lara Grau-López, Hospital Universitari Vall d Hebron. Barcelona, España. Symposium SY5 VIOLENCE IN DUAL DISORDERS: NEURAL CORRELATES AND TREATMENT Alessandra Cappai, Maudsley National Health Service Foundation Trust. London, United Kingdom. VIOLENCE AND SUBSTANCE MISUSE Alessandra Cappai, Maudsley National Health Service Foundation Trust. London, United Kingdom. TREATMENT OF VIOLENCE Mrigendra Das, Broadmoor Hospital, West London Mental Health NHS Trust, Oxford School of Psychiatry. London, United Kingdom. VIOLENCE AND NEURAL CORRELATES Carlos Parro, C.S. Mental Retiro. Hospital Universitario Gregorio Marañón. Madrid, España. Symposium SY5 ADDICTION: UNCOVERING NEUROBIOLOGICAL COMPLEXITY José E. Montejo, Universitat Autònoma de Barcelona. Hospital Universitari Vall d'hebron. Barcelona, España. www.cipd05.com Pág. 44
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 HOW THE ENVIRONMENT INTERACTS WITH GENES IN DRUG ADDICTION Bru Cormand, Universidad de Barcelona. Barcelona, España. NEUROPLASTICITY IN DRUG ADDICTION: INTERACTIVE SYSTEM OF MOLECULAR COMMUNICATION Julio Campos, Neuropsychiatric Research Lab. Universidad Central de Venezuela. Caracas, Venezuela. NEUROBIOLOGICAL COMPLEXITY Ruben Baler, National Institute on Drug Abuse. MD, USA. THERAPEUTICS IN ADDICTION: WHAT IS THE TARGET? José E. Montejo, Universitat Autònoma de Barcelona. Hospital Universitari Vall d'hebron. Barcelona, España. 08:30 0:00 Room 8-9 Track: Behavioral Addictions / Gambling Invited Symposium - IS4 GAMBLING AND DUAL DISORDERS. WHAT YOU ALWAYS WANT TO KNOW ABOUT BEHAVIORAL ADDICTIONS Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. EATING DISORDERS AND BEHAVIORAL ADDICTIONS. MEET WITH THE UNEXPERT Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. EPIDEMIOLOGY GAMBLING DISORDER AND DRUG DEPENDENCE Enrique Echeburua, Facultad de Psicología-Universidad País Vasco, España. GAMBLING DISORDER TREATMENT Susana Jiménez, Hospital Universitario de Bellvitge-IDIBELL. Barcelona, España. 08:30 09:5 Room 0 Track: Sexual Dysfunction and Dual Workshop - WS4 SEXUAL DYSFUNCTION AND SEXUAL HEALTH NEEDS OF PEOPLE WITH DUAL DISORDER: EVIDENCE AND PRACTICE Elizabeth Hughes, University of York. York, United Kingdom. SEXUAL HEALTH NEEDS OF PEOPLE WITH DUAL DISORDERS Elizabeth Hughes, University of York. York, United Kingdom. SEXUAL DYSFUNCTION AS A SIDE -EFFECT OF PSYCHOTROPIC MEDICINES FOR PEOPLE WITH DUAL DISORDERS Ian Hamilton, University of York. York, United Kingdom. 09:5 0:00 Room 0 Track: Psychotherapeutic Treatment in Dual Workshop - WS5 MAKING TREATMENT MORE ACCESSIBLE FOR PEOPLE WITH DUAL DISORDERS Chair/ Speaker: Jim Bott, Roosevelt Hospital, NY, USA. www.cipd05.com Pág. 45
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 09:5 Room Track: Multidisciplinary Intervention in Dual 09:5 0:00 Room Track: Alcohol 08:30 0:00 Room Workshop WS6 TREATING DUAL DISORDERS IN YOUNG ADULTS WITH A MULTIDISCIPLINARY NON- CONVENTIONAL STRUCTURED APPROACH Chair/ Speaker: Susana E. Méndez, Enterhealth, Residential and Outpatient Services, Dallas TX, USA. Workshop WS7 ALCOHOLISM IN ASIA: INCREASE IN PSYCHIATRY COMORBIDITY AND ITS COMORBID DISORDERS Aravind Vaithiyam, Ram Psychiatry Hospital. Madurai, India. ALCOHOLISM IN INDIA Aravind Vaithiyam, Ram Psychiatry Hospital. Madurai, India. RELAPSE PREVENTION IN ALCOHOLISM - PHARMACOLOGICAL MANAGEMENT Sujai Subramanian, Aashiana Psychiatric Care Hospital. Delhi, India. OVERLOOKED AND OVERDIAGNOSED COMORBID DEPRESSION IN ALCOHOLISM Takahiko Inagaki, Shiga University of Medical Science. Shiga, Japan. Oral Communications - OC09 Chairs: Amanda Rodríguez, Vall d'hebron University Hospital, Barcelona, Spain. Jorge Ocampo, Mexican Academy of Dual Pathology (AMEPAD), Mexico. POSTTRAUMATIC STRESS SYMPTOMS AND RELATIONSHIP TO DRUG AND ALCOHOL USE IN AN INTERNATIONAL SAMPLE OF LATIN AMERICAN IMMIGRANTS Lisa R. Fortuna, Ye Wang, Michelle Porche, Zorangeli Ramos Center for Multicultural Mental Health Services Research, Cambridge Health Alliance, Cambridge, MA, USA. Wellesley Centers for Women, Wellesley College, Wellesley. MA, USA. THERAPEUTIC ITINERARY IN SITUATIONS OF COMORBIDITY: INTEGRATION AND EQUALITY IN THE HEALTH SYSTEM - BRAZIL A. Assis, M. Silva State University of Rio de Janeiro RJ, Brasil. SEX TRADING AMONG MEN AND WOMEN ENTERING TREATMENT FOR DRUG MISUSE IN ENGLAND: ASSOCIATIONS WITH MENTAL WELLBEING G. Gilchrist, A. Jones, M. Donmall, N. Singleton. King s College London, London, United Kingdom.. University of Manchester, Manchester, United Kingdom. THE IMPACT OF RACIAL DISCRIMINATION ON SUBSTANCE USE IN THE LATIN AMERICAN IMMIGRANT POPULATION Alba-Irene González, Adriana Reyes, Zorangeli Ramos, Claudia González López 3, Francisco www.cipd05.com Pág. 46
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Collazos Hospital Universitari Vall d Hebron, Universitat Autònoma de Barcelona, CIBERSAM, España. Center for Multicultural Mental Health Research and Harvard Medical School, Boston. MA, USA. 3 Hospital Universitario Fundación Jiménez Díaz, Madrid, España. EFFECTIVENESS OF THE PERSONAL STRENGTHS INTERVENTION (PSI) ON IMPROVING THE STUDENTS WITH LEARNING DISABILITIES IN IRAN S. Piryaei, M. Khademi Ashkezari Alzahra University, Tehran, Iran. SUBSTANCE USE AND THE PROTECTIVE EFFECT OF MATERNAL WARMTH O. Santesteban,, M. Ramos-Olazagasti, R. E. Eisenberg, H. R. Bird, G. Canino 3, C. S. Duarte Columbia University Medical Center - N.Y. Psychiatric Institute, New York, NY, USA. Universitat Rovira i Virgili, Reus, Tarragona, España. 3 Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico. THE STUDY OF AGGRESSION LEVEL IN PATIENTS WITH COMPUTER ADDICTION AND COMORBID PSYCHIATRIC DISORDERS D.C. Mavani, A.V. Dyachenko, V.A. Soldatkin, O.A. Bukhanovskaya Scientific Center for Treatment and Rehabilitation "Phoenix", Rostov-On-Don, Russia. Rostov State Medical University, Rostov-On-Don, Russia. 0:00 :30 h. DUAL DIAGNOSIS IN PRIVATE PRACTICE IN MOROCCO M. Paes Mohamed V University in Rabat, Morocco. 0:00 :30 Room Track: Cannabis and Dual Symposium SY53 PATTERNS OF CANNABIS USE THROUGH THE LIFESPAN IN DUALLY AND NON-DUALLY DIAGNOSED PATIENTS Nieves Martínez-Luna, Hospital Universitari Vall d Hebron. Barcelona, España. PATTERNS OF CANNABIS USE, AND THE PRESENCE OF DUAL DIAGNOSIS IN CHILDREN AND TEENAGERS Javier Goti, Hospital Clinic. Barcelona, España. PATTERNS OF CANNABIS USE IN ADULTS -8 TO 55 YEARS- AND THE PRESENCE OF DUAL DIAGNOSIS Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy. PATTERNS OF CANNABIS USE IN ADULTS -56 YEARS AND IN OLDER LIFE- AND THE PRESENCE OF DUAL DIAGNOSIS www.cipd05.com Pág. 47
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Begoña Gonzalvo, Centre d'atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España. 0:00 :30 Room 3 Track: Sexual Dysfunction Invited Symposium - IS5 THE INTERCOURSE OF SEXUAL ADDICTION AND DUAL DISORDERS Josep Mª Farré, Hospital Universitario Quirón-Dexeus. Barcelona, España. NEW TRENDS IN SEXUALITY AND DRUGS José Antonio Navarro, Hospital Universitario Vall d Hebron de Barcelona/Clínica Galatea. Barcelona, España. SEX ADDICTION: COMORBIDITY WITH DRUGS AND OTHER PATHOLOGIES Josep Mª Farré, Hospital Universitario Quirón-Dexeus. Barcelona, España. SEXUAL LIFE AFTER PSYCHOTROPIC DRUGS Victoria Ferrer Olives, España. 0:00 :30 Room 4 Track: Evaluation processes in Dual Symposium SY54 MEDICAL COMORBIDITY IN DUAL PATHOLOGY Maite San Emeterio, Centre d Higiene Mental Les Corts. Barcelona, España. SOMATIC ATTENTION AND PROTOCOL TO DUAL PATIENT Maite San Emeterio, Centre d Higiene Mental Les Corts. Barcelona, España. HIV IN DUAL PATIENT José Mª Vazquez, Centre d'atenció i Seguiment de Sants. Barcelona, España. NEUROLOGICAL COMORBIDITY IN YOUNG DUAL PATIENT Carolina Franco, Centre d Higiene Mental Les Corts. Barcelona, España. 0:00 0:45 Room 5 Book Presentation - BP0 NEW PSYCHOACTIVE DRUGS Chair/ Speaker: Helen Dolengevich Segal, Hospital Universitario del Henares. Madrid, España. 0:45 :30 Room 5 Track: Evaluation processes in Dual Workshop WS8 DUAL DISORDERS IN MENTAL HEALTH PATIENTS Marcela Waisman, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI). Buenos Aires, Argentina. SCHIZOAFFECTIVE DISORDER AND ADDICTIONS Marcela Waisman, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI). Buenos Aires, Argentina. SMOKING AND ADDICTIONS Debora Serebrisky, Centro de Investigaciones Clínicas WM, Argentina. AUTISM SPECTRUM DISORDER AND ADDICTIONS Bettina Ortiz, Cátedra de Psiquiatría del Hospital de Clínicas, Asunción, Paraguay. www.cipd05.com Pág. 48
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 0:00 :30 Room 6 Track: Penitentiary (Prisons) and Dual 0:00 :30 Room 7 Track: Multidisciplinary Intervention in Dual 0:00 0:45 Room 8-9 Track: Psychosis 0:45 :30 Room 8-9 Track: Alcohol Symposium - SY55 DUAL DISORDERS IN SUBSTANCE USERS IN THE CRIMINAL JUSTICE SYSTEM - CLINICAL COURSE AND THE EFFECT OF TREATMENT Anders Hakansson, Lund University. Lund, Sweden. OPIATE USE AS A RISK FACTOR FOR CRIMINAL RECIDIVISM, IN-PATIENT TREATMENT AND DEATH IN CRIMINAL JUSTICE CLIENTS - POTENTIAL FOR INTERVENTION Anders Hakansson, Lund University. Lund, Sweden. SUBSTANCE USE DISORDERS AND CO-MORBIDITY WITH PSYCHIATRIC DISEASE IN THE CRIMINAL JUSTICE SETTING - POTENTIAL FOR INTERVENTION Johan Franck, Karolinska Institute. Solna, Sweden. RISK FACTORS FOR OVERDOSES, SUICIDES AND SELF-INFLICTED DEATH WITH UNDETERMINED INTENT IN CRIMINALS WITH SUBSTANCE USE PROBLEMS Martin Olsson, Lund University. Lund, Sweden. LONG TERM RISK OF SUBSTANCE-INDUCED AND PRIMARY PSYCHOSIS AFTER RELEASE FROM PRISON. A LONGITUDINAL STUDY OF SUBSTANCE USERS Eline Borger-Rognli, Oslo University. Oslo, Norway. Symposium SY56 DEVELOPING THE CAPABILITIES OF THE MENTAL HEALTH AND SUBSTANCE USE TREATMENT WORKFORCE FOR DUAL DISORDERS: EXAMPLES FROM RESEARCH AND PRACTICE Elizabeth Hughes, University of York. York, United Kingdom. ESTABLISHING AND MAINTAINING A LOCAL DUAL DIAGNOSIS NETWORK Elizabeth Hughes, University of York. York, United Kingdom. LEARNING FROM SUBSTANCE USE INCIDENTS Cheryl Kipping, Maudsley National Health Service Foundation Trust. London, United Kingdom. MENTAL HEALTH WORKERS EXPERIENCE OF USING MOTIVATIONAL INTERVIEWING FOR DUAL DISORDERS Justine Trippier, National Health Service Foundation Trust. London, United Kingdom. ESTABLISHING AND MAINTAINING A LOCAL DUAL DIAGNOSIS NETWORK Ian Hamilton, University of York. York, United Kingdom. Main Lecture ML SUBSTANCE USE AND SCHIZOPHRENIA: RISK AND REWARD Jerónimo Sáiz, Universidad de Alcalá de Henares, Madrid, España. Speaker: Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. Main Lecture ML3 PERSONALIZED TREATMENT OF ALCOHOL USE DISORDER WITH TOPIRAMATE Juan Gibert, Universidad de Cádiz, España. Speaker: Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA. www.cipd05.com Pág. 49
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 0:00 0:45 Room 0 Track: Personality 0:45 :30 Room 0 Track: Psychosis CANCELLED 0:00 0:45 Room Track: Psychopharmacological Treatments in Dual 0:45 :30 Room Track: Multidisciplinary Intervention in Dual 0:00 :30 Room Workshop WS9 PSYCHOLOGICAL PROBLEMS AMONG CHILDREN WHO ARE SEXUALLY ABUSED Chair/ Speaker: Md.Masbah Uddin Ahmed, Bandhu Social Welfare Society. Dhaka, Bangladesh. Workshop WS0 TRENDS OF TISSUE SELECTION IN EPIGENETIC INVESTIGATIONS IN MAJOR PSYCHOSES: NECESSITY FOR A UNIFIED FRAMEWORK IN PSYCHIATRIC EPIGENETIC STUDIES? Bahar Massih, Tarbiat Modares University, Bahar Medical Laboratory. Tehran, Iran. Workshop WS PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL DISORDERS: THE CASE OF SCHIZOPHRENIA AND SUBSTANCE ABUSE Luis A. Núñez, Centro Médico de Diagnóstico. Pamplona, Navarra, España. PALIPERIDONE PALMITATE IN DUAL DIAGNOSIS. A RETROSPECTIVE STUDY Luis A. Núñez, Centro Médico de Diagnóstico de Pamplona. Navarra, España. CURRENT TENDENCIES IN PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL PATHOLOGY María García, Centro Salud Mental de Tudela. Navarra, España. SCHIZOPHRENIA AND COMORBID SUBSTANCE ABUSE. AN UPDATE Olga Arbeo, Centro de Día Zuría, Pamplona. Navarra, España. Workshop - WS DUAL DISORDERS: NEW PROBLEMS, NEW SOLUTIONS Juan J. Hernández, Cruz Roja Española. Madrid, España. MULTI-CHANNEL INFORMATION AND DRUG PREVENTION SERVICE OF SPANISH RED CROSS Cristina Ferrero, Cruz Roja Española. Madrid, España. PREVENTION SERVICE AND TREATMENT OF ADDICTION TO TECHNOLOGY Silvia Allué, Asociación Punto Omega, Móstoles. Madrid, España. POST-DISCHARGE MONITORING PROGRAM OF THE SPANISH RED CROSS Juan J. Hernández, Cruz Roja Española. Madrid, España. Oral Communications - OC0 Chairs: Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d Hebron, Barcelona, España. Florence Vorspan, Publique-Hôpitaux de Paris, France. POST HOC ANALYSES OF THE EFFICACY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS PREVIOUSLY TREATED WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER MEDICATION L.A. Adler, J. Wu, M. Madhoo, B. Caballero 3 New York University School of Medicine, New York, NY, USA. Shire, Wayne, PA, USA. 3 Shire, Zug, Switzerland. www.cipd05.com Pág. 50
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 INTEGRATIVE PROGRAM MODEL [IPM]: DIALECTICAL BEHAVIOR AND PSYCHODYNAMICALLY INFORMED GROUP PSYCHOTHERAPY Claudia Arlo Addiction Institute of NY, Mt Sinai Roosevelt Hosp./Fordham University. NY, USA. ANXIETY IN ADDICTIONS Antonio Domingo Pisano Hospital J.T. Borda, Buenos Aires, Argentina. ANXIETY DISORDERS ARE ASSOCIATED WITH EARLY ONSET OF HEROIN USE AND RAPID TRANSITION TO DEPENDENCE IN METHADONE MAINTAINED PATIENTS Emily Karsinti, Vanessa Bloch, Jan Scott, Jean Pierre Lépine, Frank Bellivier, Florence Vorspan APHP - Hôpital Fernand Widal, Paris, France. Institute of Neuroscience, Newcastle University; Centre for Affective, Institute of Psychiatry, London, United Kingdom. ASSESSMENT OF DEPRESSION AND ANXIETY IN PATIENTS WITH TREATED AND UNTREATED RESISTANT HYPERTENSION: A PILOT STUDY A.Mermerelis, A. Douzenis, S-M Kyvelou, Vellinga A, C. Stefanadis 3, C. Papageorgiou 4 Galway University Hospital, Ireland. nd psychiatry clinic Athens University, Greece. 3 st cardiology clinic Athens University, Greece. 4 st psychiatry clinic Athens University, Greece. PERSONALITY CHARACTERS AND TENDENCY TO ADDICTION: A COMPARATIVE STUDY BETWEEN ADDICTED AND NONADDICTED PEOPLE Gholamali Nikpour, Alireza Homayouni, Arsalan Khanmohammadi Otaghsara 3, Seyed Jalal Mosavi Amiri 4 Allameh Tabatabaii University, Tehran, Iran. College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran. 3 College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran. 4 Medical Clinic of Dr. Mosavi, Amirkola, Iran. ANXIETY AND ALCOHOL CONSUMPTION Delia Marina Podea,, Karol-Julien Wild, Ionela Natalia Cotos, Vasile Goldis Western University of Arad -Psychiatry Department, Romania. County Clinical Emergency Hospital of Arad- Psychiatry Department, Romania. BORDERLINE PERSONALITY DISORDER AND SUBSTANCE USE DISORDER: ARE THEY A REAL COUPLE? T. Sousa-Ferreira, M. Ferreira, S. Ferreira, J. Amaral, T.Cabral. Department of Psychiatry And Mental Health - Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal. www.cipd05.com Pág. 5
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05. Department of Psychiatry And Mental Health Hospital de Braga, Braga, Portugal. :30 3:00 h. PROFESSIONALS WORKING WITH PATIENTS WITH ATTACHMENT DISORDER AND DUAL DIAGNOSIS- HOW TO NAVIGATE IN PROJECTIVE IDENTIFICATIONS C. Madsen, A.L.Kronborg Municipality of Skanderborg, Skanderborg, Denmark. :30 :5 Room Track: Depression :5 3:00 Room Track: Suicide & Dual CANCELLED :30 3:00 Room 3 Track: Psychopharmacological Treatments in Dual :30 3:00 Room 4 Track: Planning, regulations and resource management Main Lecture - ML4 DEPRESSION AND DUAL DISORDERS J. Manuel Menchón, Hospital Universitari de Bellvitge. Barcelona, España. Speaker: Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España. Main Lecture - ML5 SUICIDE Lucas Giner, Universidad de Sevilla. Sevilla, España. Speaker: Leo Sher, Mount Sinai School of Medicine/James J. Peters Veterans Administration Medical. NY, USA. Symposium SY57 DUAL PATHOLOGY TREATMENT IN DRUG ADDICTION CENTERS Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España. ANXIETY-DEPRESSION DISORDERS IN ALCOHOLIC PATIENTS. A PERSPECTIVE FROM A CAD (DRUG ADDICTION TREATMENT CENTER) Pilar San Juan, Centro de Atención a Las Drogodependencias de Villaverde. Madrid, España. USE OF ATYPICAL ANTIPSYCHOTICS IN DUAL DIAGNOSIS Dolores Baño, Centro de Atención a Drogodependencias de Majadahonda. Madrid, España. OPIOID SYSTEM IN PATIENTS WITH BORDERLINE PERSONALITY DISORDER THAT ARE GOING TO DRUG ADDICTS CARE CENTER FOR ALCOHOL AND OPIOID DEPENDENCE Rocío Molina, Centro de Atención a Las Drogodependencias de Arganzuela. Madrid, España. Invited Symposium IS6 INTEGRATED RESOURCES IN DUAL DISORDERS Luis Alfonzo B., Organización Panamericana de la salud, Washington, DC, USA. ADMISSION UNITS IN DUAL PATHOLOGY Célia Franco, Unidade de Patologia Dual, Centro Hospitalar Universitário de Coimbra, www.cipd05.com Pág. 5
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Portugal. RESOURCES IN DUAL PATHOLOGY Carlos Roncero, Universidad Autónoma de Barcelona, España. EVOLUTION AND CURRENT STATUS OF THE DUAL PATHOLOGY IN MEXICO Jorge Ocampo, Mexican Academy of Dual Pathology (AMEPAD), Mexico. MANAGEMENT OF DUAL INTEGRAL PATHOLOGY IN PSYCHIATRIC HOSPITAL IN MEXICO Juan Rosales, Mexican Academy of Dual Pathology, Mexico. :30 :5 Room 5 Track: Basic research in Dual :5 3:00 Room 5 Track: Multidisciplinary Intervention in Dual :30 3:00 Room 6 Track: Psychosis Workshop - WS3 CONCISE EMOTIONAL INTEGRAL TREATMENT PROGRAM IN DUAL DISORDERS: A PILOT STUDY Araceli García, Investigación Psicológia en UNED. Madrid, España. Araceli García, Investigación Psicológia en UNED. Madrid, España. Vicent Plá, Proyecto Hombre de Gandía. Comunidad Valenciana, España. Workshop - WS4 UPDATING THE APPROACH TO DUAL PATIENTS AT THE GENERAL HOSPITAL Francisco J. Quintero, Hospital Universitario Infanta Leonor. Madrid, España. SOMATIC COMORBIDITY IN DUAL PATIENT Fernando Mora, Hospital Infanta Leonor. Universidad de Alcalá. Madrid, España. ADDRESSING THE TURMOIL IN THE DUAL PATIENT Javier Correas, Hospital Universitario del Henares. Madrid, España. HCV AS A MARKER OF SEVERITY IN PATIENTS WITH DUAL DIAGNOSIS Helen Dolengevich, Hospital Universitario del Henares. Madrid, España. New Forum - NF0 THE COLORFUL SPECTRUM OF DUAL DISORDERS Arnt Schellekens, Radboud University, Nijmegen Institute for Scientist Practitioners in Addiction. Nijmegen, The Netherlands. ALTERED REWARD PROCESSING DEFICITS IN ADHD AND CO-OCCURRING SUBSTANCE USE DISORDERS Arnt Schellekens, Radboud University, Nijmegen Institute for Scientist Practitioners In Addiction. Nijmegen, The Netherlands. DEMORALIZATION IN DUALLY DIAGNOSED PATIENTS Gerdien de Weert, Radboud University, Nijmegen Institute for Scientist Practitioners In Addiction. Nijmegen, The Netherlands. PSYCHOTRAUMA AND ADDICTION Tim Kok, Tactus Addiction Treatment. Enschede, The Netherlands. ACUTE AND CHRONIC EFFECTS OF CANNABINOIDS ON BRAIN: PATHWAYS TO PSYCHOSIS www.cipd05.com Pág. 53
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Albert Batalla, Tactus Addiction Treatment. Deventer, The Netherlands. DUAL DIAGNOSES IN A SAMPLE OF SEVERELY CRIMINAL FEMALE OFFENDERS Eric Blaauw, Verslavingszorg Noord Nederland (VNN). Groningen, The Netherlands. PSYCHOPATHOLOGY AMONG GHB USERS Rama Kamal, Novadic-Kentron Addiction Care Netwerk. Vught, The Netherlands. :30 3:00 Room 7 Track: Multidisciplinary Intervention in Dual Symposium SY58 HOW TO TREAT DUAL PATIENTS: EXPERIENCE OF DUAL PATHOLOGY UNITS António G. da Silva, Associaçâo Brasileira de Psiquiatria. Rio de Janeiro, Brasil. EVALUATION OF TREATMENT IN A DUAL PATHOLOGY UNIT, ADDICTION INSTITUTE OF MADRID SALUD Diego Urgelés, Clínica Nuestra Señora de La Paz. Madrid, España. TREATMENT PHASES IN DUAL PATIENTS Vera Martins, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. PHARMACOLOGICAL INTERVENTIONS IN DUAL PATIENTS Tânia Silva, Centro Hospitalar Universitario de Coimbra, Portugal. MULTIDISCIPLINARY TEAM IN DUAL PATIENT'S TREATMENT Cândida Henriques, Centro Hospitalar Universitário de Coimbra, Portugal. :30 3:00 Room 8-9 Track: Behavioral addictions / Gambling Symposium SY59 PATHOLOGICAL GAMBLING, INTERNET ADDICTION AND THE INTRIGUING FLASHBACK: DECIPHERING THE CHALLENGING PUZZLE Arturo G. Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. GENDER DIFFERENCES AND DUAL DIAGNOSIS IN PATHOLOGICAL GAMBLERS Pinhas Dannon, Beer Yaakov-Ness Ziona MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. FLASHBACKS (FB) AND HALLUCINOGEN PERSISTING PERCEPTION DISORDER (HPPD): CLINICAL TOPICS AND TREATMENT APPROACH Arturo G. Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. COMORBIDITY OF INTERNET ADDICTION WITH OTHER PSYCHIATRIC CONDITIONS Aviv Weinstein, University of Ariel. Ariel, Israel. :30 :5 Room 0 Track: Multidisciplinary Intervention in Dual Workshop - WS5 SUBSTANCE USE & INTELLECTUAL DISABILITY Joanne E.L. Van Der Nagel, Tactus Addiction Treatment. Deventer, The Netherlands. www.cipd05.com Pág. 54
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 SUBSTANCE USE AMONG PERSONS WITH ID; DIAGNOSIS AND ASSESSMENT, CASE COORDINATION AND OUTPATIENT SERVICES Joanne Van Der Nagel, Tactus Addiction Treatment. Deventer, The Netherlands. SUBSTANCE USE AMONG PERSONS WITH ID; AN INPATIENT TREATMENT PROGRAM Fleur Vruwink, Tactus Addiction Care. Deventer, The Netherlands. :5 3:00 Room 0 Track: Behavioral addictions / Gambling :30 3:00 Room Track: Personality :30 3:00 Room Workshop WS6 UPDATE ON PATHOLOGICAL GAMBLING AND DUAL PATHOLOGY MANAGEMENT César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. César A. Sánchez-Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. Irene Chitty, Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. Symposium SY60 PERSONALITY AND ADDICTION: NEW ADVANCES, NEW CONTROVERSIES Lola Peris, Centre Neuchâtelois de Psychiatrie (CNP), Neuchâtel, Switzerland. PERSONALITY, PERSONALITY DISORDERS AND ADDICTION: THE ISSUES OF THEIR NEUROBIOLOGICAL LINK Lola Peris, Centre Neuchâtelois de Psychiatrie (CNP), Neuchâtel, Switzerland. MUST WE WAIT TO DIAGNOSE DUAL PERSONALITY DISORDERS? Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. USE OF SUBSTANCES AND SUICIDE: THE ROLE OF PERSONALITY TRAITS Víctor Pérez-Sola, CIBERSAM / Hospital del Mar, Barcelona, España. Oral Communications - OC Chairs: Mar Ramos, Hospital Universitari Vall d'hebron. Barcelona, España. Yenny Saad, Faculta de Medicina de la Universidad de la República del Uruguay, Uruguay. POLY-DRUG USE AND MENTAL DISTRESS COMORBIDITY: A 0-YEAR PROSPECTIVE STUDY OF PATIENTS FROM SUBSTANCE ABUSE TREATMENT IN NORWAY J. Burdzovic Andreas, G. Lauritzen, T. Nordfjærn Norwegian Institute for Alcohol and Drug Research (SIRUS), Oslo, Norway. TOBACCO USE AND BIPOLAR DISORDER. THE BRIEF INTERVENTION AT COMMUNITY MENTAL HEALTH V. Millán Aguilar Rodríguez, C. García Caro, M. Ayora Rodrírguez, E. Rodríguez Jimenez, A. www.cipd05.com Pág. 55
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Ruiz Arcos, A. Padilla Mata, M. Ordovás Gonzalez, L. Asensio Aguerri, E. Prieto Bonilla, F. Sarramea Crespo Hospital Universitario Reina Sofía, Córdoba, España. BIPOLAR DISORDER AND SUBSTANCE USE DISORDER COMORBIDITY: CYCLOTHYMIC ENDOPHENOTYPE S. Kesebir, O. Noyan, S. Nurmedov, A.E. Darcin Uskudar University, Istanbul, Turkey. Kanuni State Hospital, Istanbul, Turkey. DISPARITIES IN ACCESS AND EFFECTIVENESS FOR EVIDENCE-BASED SUPPORTED EMPLOYMENT FOR PERSONS WITH CO-OCCURRING SERIOUS MENTAL ILLNESS (SMI) AND SUBSTANCE USE DISORDER (SUD): EVIDENCE FROM A STATE-WIDE POLICY INTERVENTION David Salkever, Brent Gibbons, Michael Abrams 3, Kevin Baier The School of Public Policy at the University of Maryland-Baltimore County (UMBC); Johns Hopkins-Bloomberg School of Public Health, Johns Hopkins University. MA, USA. Maryland Institute for Policy Analysis and Research and the School of Public Policy, UMBC. MA, USA. 3 Hilltop Institute and the School of Public Policy, UMBC. MA, USA. EFFECT OF TOBACCO ABSTINENCE AND BUPROPION AUGMENTATION ON COGNITIVE FUNCTION IN SCHIZOPHRENIC PATIENTS: A DOUBLE-BLIND PLACEBO AND CONTROLLED STUDY Najmeh Shahini,, Mansoreh Mirzadeh., Mohammad Reza Fayyazi Bordbar. Psychiatry and Behavioural Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine. Mashhad, Iran. Mashhad University of Medical Sciences, Mashhad, Iran. PSYCHOSIS AFTER OPIOD WITHDRAWAL ARE OPIOID DRUGS ANTYPSYCHOTICS? V. Vila Nova, C. Oliveira, C. Cotta Centro Hospitalar Barreiro-Montijo, Barreiro, Portugal. Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal. NEUROBEHAVIORAL ASPECTS OF OMEGA-3 FATTY ACIDS: POSSIBLE MECHANISM AND THERAPEUTIC VALUE IN DUAL DIAGNOSIS S. Rabinovitz University of Haifa, Haifa, Israel. NEUROCOGNITIVE CHARACTERISTICS OF PSYCHOTIC SYMPTOMS IN YOUNG ADULTS WITH HIGH FUNCTIONING AUTISM R. Rinaldi,, E. Jacquet 3, L. Lefebvre, Neuropsychology and Cognitive Sciences Department, University of Mons, Belgium. UMONS Research Institute for Health Sciences and Technology, University of Mons, Belgium. 3 Faculty of Psychology and Educational Sciences, University of Mons, Belgium. www.cipd05.com Pág. 56
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 POLITICS AND ECONOMICS OF METHADONE IN RURAL CANADA Sanjay Siddhartha, Ajay Wagle Miramichi Hospital, Miramichi, Canada. 3:00 4:30 h. Norwich NHS Trust, Canada. 3:00 4:30 Room Track: Psychopharmacological Treatments in Dual 3:00 4:30 Room 3 Track: Epidemiology and Dual Symposium SY6 PARKINSON'S DISEASE, HEADACHE AND CHRONIC FATIGUE SYNDROME: EXPLANATORY MODELS OF NEUROBIOLOGICAL MECHANISMS OF SUBSTANCE USE DISORDERS Luis Sánchez Planell, Universidad Autónoma de Barcelona, España. DISORDERS OF IMPULSE CONTROL AND DOPAMINE DYSREGULATION SYNDROME IN PARKINSON'S DISEASE Naia Sáez-Francàs, Hospital Vall d'hebron. Barcelona, España. IS PERSONALITY A FACTOR INVOLVED IN THE APPEARANCE OF CHRONIC FATIGUE SYNDROME AND ITS RELATION TO SUBSTANCE USE DISORDERS? Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. HEADACHE AND MISUSE OF MEDICATION Patricia Pozo, Servicio de Neurología, Hospital Vall d Hebron, Barcelona, España. Symposium - SY6 RESULTS FROM THE CO-OCCURRING DISORDERS MULTICENTER STUDY IN MEXICAN RESIDENTIAL CENTERS Rodrigo Marin-Navarrete, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Ciudad de México, México. CO-OCCURRING DISORDERS IN RESIDENTIAL CENTERS A PUBLIC HEALTH CONCERN IN MEXICO Rodrigo Marin-Navarrete, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Ciudad de México, México. LATENT CLASS PROFILE OF SEXUAL RISK BEHAVIOR AND CO-OCCURRING DISORDERS IN A SAMPLE OF RESIDENTIAL PATIENTS Luis Villalobos-Gallegos, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Universidad Autonómica Nacional. Ciudad de México, México. PREVALENCE AND CORRELATES OF CO-OCCURRING DISORDERS IN A FEMALE SUB-SAMPLE: A SECONDARY ANALYSIS Ana de la Fuente, Universidad La Salle. Ciudad de México, México. 3:00 4:30 Room 4 Invited Symposium - IS7 DUAL DISORDERS: NEW PHARMACOLOGICAL TREATMENTS www.cipd05.com Pág. 57
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Track: Psychopharmacological Treatments in Dual Diego Palau, Corporació Sanitaria i Unviersitari Parc Taulí, Sabadell. Barcelona, España. Speaker: VARENICLINE IN SMOKING CESSATION THROUGH SMOKING REDUCTION Eugeni Bruguera, Hospital Universitari Vall d'hebron. Barcelona, España. PHARMACOLOGICAL ADVANCES IN THE MODULATION OF NICOTINIC CHOLINERGIC SYSTEMS: THERAPEUTIC IMPLICATIONS IN DUAL PATHOLOGY Cecilio Álamo, Universidad de Alcalá, Hospital de la Paz, España. ADDRESSING TOBACCO CESSATION IN AN INPATIENT ADDICTION UNIT Mª Cristina Pinet, Hospital de la Santa Creu i Sant Pau. Barcelona, España. 3:00 4:30 Room 5 Track: Attention Deficit 3:00 4:30 Room 6 Track: Legal aspects in Dual Symposium - SY63 DIFFERENTIAL ASPECTS IN ADULTS WITH ADHD IN DIFFERENT SUBSTANCE USE DISORDERS José R. Gutiérrez, Hospital Perpetuo Socorro. Badajoz, España. TRANSLATIONAL ASPECTS AND CLINICAL UTILITY OF MANAGEMENT OF ADHD IN ADULTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES José R. Gutiérrez, Hospital Perpetuo Socorro. Badajoz, España. GENERAL AND SPECIFIC FREQUENCY OF ADHD IN A SAMPLE OF ADULT PATIENTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES: ANALYSIS OF THE SAMPLE. José M. Zoido, Centro Extremeño de Atención a la Drogodependencia. CEDEX. Badajoz, España. INFLUENCES OF AFFECTIVE VARIABLES IN THE ASSESSMENT OF ADHD IN A SAMPLE OF ADULTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES Francisco J.R.Pino, Unidad de Salud Mental de Montijo. Badajoz, España. Symposium SY64 THREE REALITIES IN A SINGLE PATIENT IN HEALTHCARE SERVICES FOR DRUG ADDICTION AND DUAL PATHOLOGY Isabel Aguilar, Santa Cruz de Tenerife, España. THE NEED FOR A STRATEGY AND COORDINATION HEALTH PLAN FOR DUAL PATHOLOGY AT THE MURCIAN HEALTH SERVICE Desiderio Mejías, Hospital de la Vega Lorenzo Guirao, Cieza. Murcia, España. APPROACH TO DUAL DIAGNOSIS IN ANDALUSIA: "A CLINICAL ENTITY, TWO HEALTHCARE NETWORKS Juan Ramírez, Servicio Provincial Drogodependencias y Adicciones Huelva, España. DEPENDENCE OF DRUG ADDICTIONS ON SUBSIDY POLICIES IN THE CANARIES. REGULATIONS AND ISSUES Isabel Aguilar, Santa Cruz de Tenerife, España. www.cipd05.com Pág. 58
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 3:00 4:30 Room 8-9 Track: Gender and Dual Diagnosis Symposium - SY65 DUAL DISORDERS IN A TRANSSEXUALITY AND GENDER IDENTITY UNIT FROM THE PUBLIC HEALTH SERVICE. RESEARCH, MANAGEMENT AND INTERVENTION Pedro M. P. Matos, Hospital Regional Universitario de Málaga. Málaga, España. RESEARCH ABOUT SUBSTANCE CONSUMPTION AND MENTAL HEALTH FROM THE MINORITY STRESS MODEL PERSPECTIVE José Gúzman, Hospital Regional Universitario de Málaga. Instituto de Investigación Biomédica. Málaga, España. VICTIMIZATION AND VIOLENCE AND ITS RELATION WITH SUBSTANCE USE IN TRANSSEXUALS Pedro M. Paulino Matos, Hospital Regional Universitario de Málaga. Málaga, España. SUBSTANCE USE AND SUICIDAL BEHAVIORS IN TRANSSEXUALS' INDIVIDUALS Lucía Pérez, Hospital Regional Universitario de Málaga. Universidad de Málaga. Málaga, España. 3:00 4:30 Room Oral Communications - OC Chairs: Josep Salavert, Hospital San Rafael, Barcelona, España. Mariano Montenegro, Universidad de Chile, Santiago, Chile. DOES DRUG-INDUCED PSYCHOSIS REALLY EXIST? Luis Alfonso Núñez Domínguez, María García Nicolas, Olga Arbeo Ruiz 3 Centro Médico. España. Centro Salud Mental Tudela. España. 3 Centro de Día Zuría. España. AGE RELATED EFFECTS ON COGNITIVE FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA AND COCAINE DEPENDENCE I.Benaiges, J.M. Serra-Grabulosa,, A. Adan,3 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, España. August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, España. 3 Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España. CLINICAL FEATURES OF SCHIZOPHRENIA IN PERSONS USING NARCOTIC SUBSTANCES OF THE OPIUM ROW N.A. Bokhan, A.V. Semke, A.P. Sidenkova, A.F. Abolonin Mental Health Research Institute SB RAMSci, Tomsk, Russia. Ural State Medical University, Yekaterinburg, Russia. TOXIC PSYCHOSIS VS DUAL PATHOLOGY: LONGITUDINAL EVALUATION OF PATIENTS ADMITTED TO THE PSYCHIATRY DEPARTMENT OF HOSPITAL GARCIA DE ORTA www.cipd05.com Pág. 59
Monday April 0 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 S. Coelho, A. Roberto, D. Sennfelt Hospital Garcia de Orta, Lisbon, Portugal. ZIPRASIDONE VS. CLOZAPINE IN THE TREATMENT OF DUALLY DIAGNOSED (DD) PATIENTS WITH SCHIZOPHRENIA AND CANNABIS USE DISORDERS: A RANDOMIZED STUDY E. Gouzoulis-Mayfrank,, T. Schnell,3 University Hospital of Cologne, Cologne, Germany. LVR Clinics Cologne, Cologne, Germany. 3 Medical School Hamburg (MSH), Hamburg, Germany. TREATING PSYCHOTIC PATIENTS WITH AGONIST OPIOID THERAPY AND ATYPICAL ANTIPSYCHOTICS Maria Chiara Pieri Drug Addiction Unit Bologna, Italy. GENDER DIFFERENCES IN RETENTION IN DUALLY DIAGNOSED ADULTS ATTENDING PRIVATE RESIDENTIAL TREATMENT IN THE U.S. Siobhan Morse Foundations Recovery Network, Brentwood, TN. USA. PSYCHOLOGICAL, ENVIRONMENTAL OR PHYSICAL FACTORS, WHICH IS THE FIRST CAUSE OF TENDENCY TO ADDICTION? Seyed Jalal Mosavi Amiri, Alireza Homayouni, Gholamali Nikpour 3, Arsalan Khanmohammadi Otaghsara 4 Medical Clinic of Dr. Mosavi, Amirkola, Iran. College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran. 3 Allameh Tabatabaii University, Tehran, Iran. 4 College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran. www.cipd05.com Pág. 60
www.cipd05.com Pág. 6
PARALLEL ACTIVITIES Thursday, April 6 th 09:00 8:00 SEPD Meeting Room Friday, April 7 th 09:00 6:00 SEPD Meeting Room NIDA RESEARCH PROJECT MEETING: INTERNATIONAL LATINO RESEARCH PARTNERSHIP By invitation only Margarita Alegría, Center for Multicultural Mental Health Research, Cambridge Health Alliance & Harvard Medical School, Somerville. MA, USA. Enrique Baca, Fundación Jiménez Díaz, Madrid, España. Francisco Collazos, Hospital Universitari Vall d'hebron, Barcelona, España. Sociedad Española de Patología Dual SEPD FOUNDATION ACTIVITIES Friday, April 7th 6:45 7:30 Room DUAL PATHOLOGY AND ART Co-organized by the Foundation on Dual Lara Grau-López, Hospital Universitari Vall d Hebron. Barcelona, España. Speaker: J. Ramon Pigem, Clínica Bellavista, Lleida, España. Friday, April 7th 6:00 8:00 Room 3 Foundation on Dual FEAFES CROSSROADS OF DUAL PATHOLOGY: THE VISION OF ASSOCIATIONS OF PEOPLE WITH MENTAL ILLNESS AND THEIR FAMILIES Chairs: Pablo Vega, Sociedad Española de Patología Dual (SEPD); Instituto de Adicciones. Madrid, España. Nel Anxelu González, Confederación Española de Agrupaciones de Familiares y Personas con Enfermedad Mental (FEAFES), España. José Mª Vázquez, CAS de Sants, Barcelona, España. Lina Mª Huertas, Confederación FEAFES, España. Rosario Tomás, CRIS de la asociación AFEPVI, Villena, Alicante, España. David Soriano, CRIS de la asociación AFEPVI, Villena, Alicante, España. Friday, April 7th, Saturday, April 8th SURVEY ON USE OF TOBACCO ON PROFESSIONALS Sponsored by the Foundation on Dual Coordinated by: Fernando W. Müller, Centro de Investigaciones Clínicas WM. Argentina. Debora Serebrisky, Centro de Investigaciones Clínicas WM. Argentina. Diana Romero, Hospital Universitario Vall d'hebron. SEPD. España. Alfonso Abad, Hospital Universitario Vall d'hebron. SEPD. España. Saturday, April 8th 4:00 6:00 PROMOTION OF THE RESEARCH NETWORKS WITH CLINICAL AND PREVENTIVE APPLICATION. ACTION 9 OF THE PND www.cipd05.com Pág. 6
SEPD Meeting Room CANCELLED By invitation only Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid, España. José Oñorbe, Delegación del Gobierno del Plan Nacional sobre Drogas, Madrid, España. Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España. María Estrada, Subdirecció General de Drogodependències, Barcelona, España. Saturday, April 8 th Room 9 08:30 09:0 09:5 09:55 4:00 4:40 4:45 5:5 5:30 6:0 6:5 6:55 Medical Educational Room Sponsored by the Foundation on Dual Language: English INFORMATION FOR PATIENTS ON INTERNET: QUALITY RESOURCES AND BLOG CREATION PUBMED ALERTS ZOTERO. CITATION MANAGEMENT SOFTWARE Language: Spanish PUBMED ALERTAS ZOTERO. GESTOR DE REFERENCIAS BIBLIOGRÁFICAS INFORMACIÓN PARA PACIENTES EN INTERNET: RECURSOS DE CALIDAD Y CREACIÓN DE BLOGS Sunday, April 9 th Room 9 09:5 09:55 Language: English INFORMATION FOR PATIENTS ON INTERNET: QUALITY RESOURCES AND BLOG CREATION :00 :40 :45 3:5 3:30 4:0 Language: Spanish PUBMED ALERTAS PUBMED FILTROS PERSONALIZADOS ZOTERO. GESTOR DE REFERENCIAS BIBLIOGRÁFICAS 4:5 4:55 5:00 5:40 Language: English PUBMED ALERTS ZOTERO. CITATION MANAGEMENT SOFTWARE 5:45 6:5 Language: Spanish INFORMACIÓN PARA PACIENTES EN INTERNET: RECURSOS DE CALIDAD Y CREACIÓN DE BLOGS www.cipd05.com Pág. 63